activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	1881815	CHEMBL904810	Inhibition of MSK2	B	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	=	IC50	nM	3010.0	CHEMBL3125	Homo sapiens	IC50	uM	3.01
	1881815	CHEMBL904810	Inhibition of MSK2	B	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	=	IC50	nM	3010.0	CHEMBL3125	Homo sapiens	IC50	uM	3.01
	1881822	CHEMBL904810	Inhibition of MSK2	B	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4)c3)cc21	Outside typical range	CHEMBL388566	=	IC50	nM	148000.0	CHEMBL3125	Homo sapiens	IC50	uM	148.0
	1881829	CHEMBL904810	Inhibition of MSK2	B	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21	Outside typical range	CHEMBL226403	>	IC50	nM	200000.0	CHEMBL3125	Homo sapiens	IC50	uM	200.0
	1881839	CHEMBL904810	Inhibition of MSK2	B	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	=	IC50	nM	58000.0	CHEMBL3125	Homo sapiens	IC50	uM	58.0
	2051581	CHEMBL942722	Inhibition of MSK2	B	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	=	Ki	nM	949.0	CHEMBL3125	Homo sapiens	Ki	uM	0.949
	2147319	CHEMBL922004	Activity of human MSK2 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	106.0	CHEMBL3125	Homo sapiens	Activity	%	106.0
	2251045	CHEMBL1011920	Inhibition of MSK2 at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL525385	=	Inhibition	%	109.0	CHEMBL3125	Homo sapiens	INH	%	109.0
	2251219	CHEMBL1009917	Inhibition of Rsk4	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	IC50	nM	10.0	CHEMBL3125	Homo sapiens	IC50	nM	10.0
Not Evaluated	2476696	CHEMBL982724	Binding affinity to human MSK2 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL3125	Homo sapiens	Activity		
Not Evaluated	2476699	CHEMBL982727	Binding affinity to human RSK4 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL3125	Homo sapiens	Activity		
Not Evaluated	2476899	CHEMBL982724	Binding affinity to human MSK2 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL3125	Homo sapiens	Activity		
Not Evaluated	2476902	CHEMBL982727	Binding affinity to human RSK4 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL3125	Homo sapiens	Activity		
	2477874	CHEMBL988907	Binding affinity to human MSK2	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Kd	nM	94.0	CHEMBL3125	Homo sapiens	Kd	nM	94.0
Not Evaluated	2478738	CHEMBL982724	Binding affinity to human MSK2 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL3125	Homo sapiens	Activity		
Not Evaluated	2478741	CHEMBL982727	Binding affinity to human RSK4 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL3125	Homo sapiens	Activity		
Not Evaluated	2479593	CHEMBL982724	Binding affinity to human MSK2 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL3125	Homo sapiens	Activity		
Not Evaluated	2479596	CHEMBL982727	Binding affinity to human RSK4 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL3125	Homo sapiens	Activity		
	2479796	CHEMBL982724	Binding affinity to human MSK2 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	13.3	CHEMBL3125	Homo sapiens	Activity	%	13.3
	2479799	CHEMBL982727	Binding affinity to human RSK4 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	20.25	CHEMBL3125	Homo sapiens	Activity	%	20.25
Active	2480593	CHEMBL982724	Binding affinity to human MSK2 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL3125	Homo sapiens	Activity		
Active	2480596	CHEMBL982727	Binding affinity to human RSK4 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL3125	Homo sapiens	Activity		
Not Evaluated	2480795	CHEMBL982724	Binding affinity to human MSK2 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL3125	Homo sapiens	Activity		
Not Evaluated	2480798	CHEMBL982727	Binding affinity to human RSK4 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL3125	Homo sapiens	Activity		
Not Evaluated	2577217	CHEMBL982727	Binding affinity to human RSK4 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL3125	Homo sapiens	Activity		
Not Evaluated	2577417	CHEMBL982724	Binding affinity to human MSK2 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL3125	Homo sapiens	Activity		
Not Evaluated	2577420	CHEMBL982727	Binding affinity to human RSK4 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL3125	Homo sapiens	Activity		
Not Evaluated	2593622	CHEMBL982724	Binding affinity to human MSK2 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL3125	Homo sapiens	Activity		
Not Evaluated	2593625	CHEMBL982727	Binding affinity to human RSK4 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL3125	Homo sapiens	Activity		
Not Evaluated	2593888	CHEMBL982724	Binding affinity to human MSK2 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL3125	Homo sapiens	Activity		
Not Evaluated	2593891	CHEMBL982727	Binding affinity to human RSK4 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL3125	Homo sapiens	Activity		
Not Evaluated	2594091	CHEMBL982724	Binding affinity to human MSK2 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL3125	Homo sapiens	Activity		
Not Evaluated	2594094	CHEMBL982727	Binding affinity to human RSK4 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL3125	Homo sapiens	Activity		
Not Evaluated	2594831	CHEMBL982724	Binding affinity to human MSK2 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL3125	Homo sapiens	Activity		
Not Evaluated	2594834	CHEMBL982727	Binding affinity to human RSK4 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL3125	Homo sapiens	Activity		
Not Evaluated	2595034	CHEMBL982724	Binding affinity to human MSK2 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL3125	Homo sapiens	Activity		
Not Evaluated	2595037	CHEMBL982727	Binding affinity to human RSK4 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL3125	Homo sapiens	Activity		
Not Evaluated	2596231	CHEMBL982724	Binding affinity to human MSK2 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL3125	Homo sapiens	Activity		
Not Evaluated	2596234	CHEMBL982727	Binding affinity to human RSK4 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL3125	Homo sapiens	Activity		
Not Evaluated	2596434	CHEMBL982724	Binding affinity to human MSK2 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL3125	Homo sapiens	Activity		
Not Evaluated	2596437	CHEMBL982727	Binding affinity to human RSK4 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL3125	Homo sapiens	Activity		
Not Evaluated	2597703	CHEMBL982724	Binding affinity to human MSK2 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL3125	Homo sapiens	Activity		
Not Evaluated	2597706	CHEMBL982727	Binding affinity to human RSK4 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL3125	Homo sapiens	Activity		
Not Evaluated	2597906	CHEMBL982724	Binding affinity to human MSK2 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL3125	Homo sapiens	Activity		
	2721659	CHEMBL1057490	Inhibition of MSK2 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL3125	Homo sapiens	INH	%	50.0
	2907779	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	7200.0	CHEMBL3125	Homo sapiens	Kd	nM	7200.0
	2907780	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907781	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	1900.0	CHEMBL3125	Homo sapiens	Kd	nM	1900.0
	2907782	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907783	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907784	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907785	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	590.0	CHEMBL3125	Homo sapiens	Kd	nM	590.0
	2907786	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907787	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907788	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907789	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907790	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907791	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907792	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907793	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	1300.0	CHEMBL3125	Homo sapiens	Kd	nM	1300.0
	2907794	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907795	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907796	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907797	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907798	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	3000.0	CHEMBL3125	Homo sapiens	Kd	nM	3000.0
	2907799	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907800	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	6100.0	CHEMBL3125	Homo sapiens	Kd	nM	6100.0
	2907801	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907802	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907803	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907804	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	260.0	CHEMBL3125	Homo sapiens	Kd	nM	260.0
	2907805	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907806	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907807	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907808	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907809	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907810	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907811	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	120.0	CHEMBL3125	Homo sapiens	Kd	nM	120.0
	2907812	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	200.0	CHEMBL3125	Homo sapiens	Kd	nM	200.0
	2907813	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	96.0	CHEMBL3125	Homo sapiens	Kd	nM	96.0
	2907814	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907815	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907816	CHEMBL1051259	Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907817	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907818	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907819	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907820	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907821	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907822	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907823	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907824	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907825	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907826	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907827	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907828	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907829	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907830	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	7000.0	CHEMBL3125	Homo sapiens	Kd	nM	7000.0
	2907831	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907832	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907833	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907834	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907835	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907836	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907837	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907838	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907839	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907840	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907841	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907842	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907843	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907844	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907845	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907846	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907847	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907848	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907849	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	2200.0	CHEMBL3125	Homo sapiens	Kd	nM	2200.0
	2907850	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	2000.0	CHEMBL3125	Homo sapiens	Kd	nM	2000.0
	2907851	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	2000.0	CHEMBL3125	Homo sapiens	Kd	nM	2000.0
	2907852	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907853	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2907854	CHEMBL1061185	Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	2921989	CHEMBL1052957	Inhibition of RPS6KA4 kinase domain 1 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL3125	Homo sapiens	Activity	%	100.0
	2921990	CHEMBL1052958	Inhibition of RPS6KA4 kinase domain 2 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	89.0	CHEMBL3125	Homo sapiens	Activity	%	89.0
	2938478	CHEMBL1041387	Inhibition of MSK2 at 1 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	6.0	CHEMBL3125	Homo sapiens	INH	%	6.0
	3052474	CHEMBL1072512	Residual activity of RPS6KA4 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	93.0	CHEMBL3125	Homo sapiens	Residual activity	%	93.0
	3052726	CHEMBL1043805	Residual activity of RPS6KA4 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	87.0	CHEMBL3125	Homo sapiens	Residual activity	%	87.0
	3054035	CHEMBL1071365	Residual activity of RPS6KA4 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	142.0	CHEMBL3125	Homo sapiens	Residual activity	%	142.0
	3055322	CHEMBL1072512	Residual activity of RPS6KA4 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	91.0	CHEMBL3125	Homo sapiens	Residual activity	%	91.0
	3055574	CHEMBL1043805	Residual activity of RPS6KA4 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	86.0	CHEMBL3125	Homo sapiens	Residual activity	%	86.0
	3056879	CHEMBL1071365	Residual activity of RPS6KA4 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	135.0	CHEMBL3125	Homo sapiens	Residual activity	%	135.0
	3057131	CHEMBL1072512	Residual activity of RPS6KA4 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	88.0	CHEMBL3125	Homo sapiens	Residual activity	%	88.0
	3058451	CHEMBL1043805	Residual activity of RPS6KA4 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	86.0	CHEMBL3125	Homo sapiens	Residual activity	%	86.0
	3059735	CHEMBL1071365	Residual activity of RPS6KA4 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	162.0	CHEMBL3125	Homo sapiens	Residual activity	%	162.0
	3213976	CHEMBL1116724	Inhibition of MSK2 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	2.0	CHEMBL3125	Homo sapiens	INH	%	2.0
	3219677	CHEMBL1110428	Inhibition of MSK2 at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1ccc(-c2ccnc(N)n2)s1)C(N)=O		CHEMBL1077375	=	Inhibition	%	112.0	CHEMBL3125	Homo sapiens	INH	%	112.0
	3224955	CHEMBL1101759	Inhibition of MSK2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL3125	Homo sapiens	INH	%	50.0
	3226334	CHEMBL1101759	Inhibition of MSK2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL3125	Homo sapiens	INH	%	50.0
	3332143	CHEMBL1167691	Inhibition of RPS6KA4 N-terminal domain1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL3125	Homo sapiens	INH	%	50.0
	3332144	CHEMBL1167692	Inhibition of RPS6KA4 C-terminal domain2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL3125	Homo sapiens	INH	%	50.0
	3333558	CHEMBL1167691	Inhibition of RPS6KA4 N-terminal domain1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL3125	Homo sapiens	INH	%	50.0
	3333559	CHEMBL1167692	Inhibition of RPS6KA4 C-terminal domain2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL3125	Homo sapiens	INH	%	50.0
	3334963	CHEMBL1167691	Inhibition of RPS6KA4 N-terminal domain1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL3125	Homo sapiens	INH	%	50.0
	3334964	CHEMBL1167692	Inhibition of RPS6KA4 C-terminal domain2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL3125	Homo sapiens	INH	%	50.0
	3336383	CHEMBL1167691	Inhibition of RPS6KA4 N-terminal domain1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL3125	Homo sapiens	INH	%	50.0
	3336384	CHEMBL1167692	Inhibition of RPS6KA4 C-terminal domain2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL3125	Homo sapiens	INH	%	50.0
	3337647	CHEMBL1167691	Inhibition of RPS6KA4 N-terminal domain1 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL3125	Homo sapiens	INH	%	50.0
	3338978	CHEMBL1167691	Inhibition of RPS6KA4 N-terminal domain1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL3125	Homo sapiens	INH	%	50.0
	3339232	CHEMBL1167691	Inhibition of RPS6KA4 N-terminal domain1 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL3125	Homo sapiens	INH	%	50.0
	3340535	CHEMBL1167691	Inhibition of RPS6KA4 N-terminal domain1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL3125	Homo sapiens	INH	%	50.0
	3341925	CHEMBL1167691	Inhibition of RPS6KA4 N-terminal domain1 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL3125	Homo sapiens	INH	%	50.0
	3341926	CHEMBL1167692	Inhibition of RPS6KA4 C-terminal domain2 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL3125	Homo sapiens	INH	%	50.0
	3343372	CHEMBL1167691	Inhibition of RPS6KA4 N-terminal domain1 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL3125	Homo sapiens	INH	%	50.0
	3343373	CHEMBL1167692	Inhibition of RPS6KA4 C-terminal domain2 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL3125	Homo sapiens	INH	%	50.0
	3358794	CHEMBL1175322	Inhibition of RPS6KA4 N-terminal domain1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	30.0	CHEMBL3125	Homo sapiens	INH	%	30.0
	3358795	CHEMBL1175323	Inhibition of RPS6KA4 C-terminal domain2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	99.0	CHEMBL3125	Homo sapiens	INH	%	99.0
	3359236	CHEMBL1175322	Inhibition of RPS6KA4 N-terminal domain1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	3.6	CHEMBL3125	Homo sapiens	INH	%	3.6
	3359237	CHEMBL1175323	Inhibition of RPS6KA4 C-terminal domain2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	87.0	CHEMBL3125	Homo sapiens	INH	%	87.0
	3368293	CHEMBL1176571	Inhibition of MSK2 at 1 uM	B	CCc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(F)cc4F)C3)c12		CHEMBL1171647	>	Inhibition	%	50.0	CHEMBL3125	Homo sapiens	INH	%	50.0
	3443518	CHEMBL1244284	Inhibition of MSK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	39.0	CHEMBL3125	Homo sapiens	INH	%	39.0
	3443735	CHEMBL1244284	Inhibition of MSK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	10.0	CHEMBL3125	Homo sapiens	INH	%	10.0
	3444890	CHEMBL1244284	Inhibition of MSK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	3.0	CHEMBL3125	Homo sapiens	INH	%	3.0
	3445290	CHEMBL1244964	Binding affinity to RPS6KA1(Kin.Dom.1-N-terminal)	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	28.0	CHEMBL3125	Homo sapiens	Kd	nM	28.0
	3445514	CHEMBL1244284	Inhibition of MSK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	4.0	CHEMBL3125	Homo sapiens	INH	%	4.0
	3445731	CHEMBL1244284	Inhibition of MSK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	44.0	CHEMBL3125	Homo sapiens	INH	%	44.0
	3445924	CHEMBL1244284	Inhibition of MSK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	19.0	CHEMBL3125	Homo sapiens	INH	%	19.0
	3446114	CHEMBL1244284	Inhibition of MSK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	9.0	CHEMBL3125	Homo sapiens	INH	%	9.0
	3448611	CHEMBL1244964	Binding affinity to RPS6KA1(Kin.Dom.1-N-terminal)	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	3448612	CHEMBL1244965	Binding affinity to RPS6KA1(Kin.Dom.2-C-terminal)	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	3449041	CHEMBL1244964	Binding affinity to RPS6KA1(Kin.Dom.1-N-terminal)	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	690.0	CHEMBL3125	Homo sapiens	Kd	nM	690.0
	3449333	CHEMBL1244964	Binding affinity to RPS6KA1(Kin.Dom.1-N-terminal)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	140.0	CHEMBL3125	Homo sapiens	Kd	nM	140.0
	3449502	CHEMBL1244965	Binding affinity to RPS6KA1(Kin.Dom.2-C-terminal)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	5000.0	CHEMBL3125	Homo sapiens	Kd	nM	5000.0
	3449838	CHEMBL1244964	Binding affinity to RPS6KA1(Kin.Dom.1-N-terminal)	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	3449839	CHEMBL1244965	Binding affinity to RPS6KA1(Kin.Dom.2-C-terminal)	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	3449958	CHEMBL1244965	Binding affinity to RPS6KA1(Kin.Dom.2-C-terminal)	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	3450230	CHEMBL1244964	Binding affinity to RPS6KA1(Kin.Dom.1-N-terminal)	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	3450231	CHEMBL1244965	Binding affinity to RPS6KA1(Kin.Dom.2-C-terminal)	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	3450860	CHEMBL1244965	Binding affinity to RPS6KA1(Kin.Dom.2-C-terminal)	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	3451139	CHEMBL1244964	Binding affinity to RPS6KA1(Kin.Dom.1-N-terminal)	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	3451140	CHEMBL1244965	Binding affinity to RPS6KA1(Kin.Dom.2-C-terminal)	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	uM	10.0
	3463351	CHEMBL1251684	Inhibition of RPS6KA4 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	97.0	CHEMBL3125	Homo sapiens	INH	%	97.0
	3463895	CHEMBL1251684	Inhibition of RPS6KA4 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	90.0	CHEMBL3125	Homo sapiens	INH	%	90.0
	3464114	CHEMBL1251684	Inhibition of RPS6KA4 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	75.0	CHEMBL3125	Homo sapiens	INH	%	75.0
	3502347	CHEMBL1259610	Inhibition of Rsk4 at 1 uM	B	Cc1c[nH]c2ncnc(N3CCN(C(=O)[C@H](N)C4Cc5ccccc5C4)CC3)c12		CHEMBL1257283	>	Inhibition	%	90.0	CHEMBL3125	Homo sapiens	INH	%	90.0
	5120418	CHEMBL1646206	Inhibition of human MSK2 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	109.0	CHEMBL3125	Homo sapiens	INH	%	109.0
	5120423	CHEMBL1646644	Inhibition of human Rsk4 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	109.0	CHEMBL3125	Homo sapiens	INH	%	109.0
	5243741	CHEMBL1685704	Inhibition of MSK2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	106.0	CHEMBL3125	Homo sapiens	INH	%	106.0
	5243849	CHEMBL1686061	Inhibition of MSK2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	91.0	CHEMBL3125	Homo sapiens	INH	%	91.0
	5243962	CHEMBL1685704	Inhibition of MSK2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	39.0	CHEMBL3125	Homo sapiens	INH	%	39.0
	5244070	CHEMBL1686061	Inhibition of MSK2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	2.0	CHEMBL3125	Homo sapiens	INH	%	2.0
	5244943	CHEMBL1685704	Inhibition of MSK2 at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	96.0	CHEMBL3125	Homo sapiens	INH	%	96.0
	5245051	CHEMBL1686061	Inhibition of MSK2 at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	54.0	CHEMBL3125	Homo sapiens	INH	%	54.0
	5245202	CHEMBL1685704	Inhibition of MSK2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	6.0	CHEMBL3125	Homo sapiens	INH	%	6.0
	5246032	CHEMBL1686061	Inhibition of MSK2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	1.0	CHEMBL3125	Homo sapiens	INH	%	1.0
	6172876	CHEMBL1769116	Inhibition of RSK4 at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC(CCO)CCO)nc21		CHEMBL1090089	>	Inhibition	%	85.0	CHEMBL3125	Homo sapiens	INH	%	85.0
	6172888	CHEMBL1769286	Inhibition of RSK4	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC(CCO)CCO)nc21		CHEMBL1090089	=	Kd	nM	150.0	CHEMBL3125	Homo sapiens	Kd	nM	150.0
	6172940	CHEMBL1769116	Inhibition of RSK4 at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	>	Inhibition	%	85.0	CHEMBL3125	Homo sapiens	INH	%	85.0
	6172952	CHEMBL1769286	Inhibition of RSK4	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	=	Kd	nM	73.0	CHEMBL3125	Homo sapiens	Kd	nM	73.0
	6339978	CHEMBL1826915	Activity of RPS6KA1(Kin.Dom.2-Cterminal) kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	83.0	CHEMBL3125	Homo sapiens	Activity	%	83.0
	6340013	CHEMBL1827251	Activity of RPS6KA1(Kin.Dom.1-Nterminal) kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	87.0	CHEMBL3125	Homo sapiens	Activity	%	87.0
	6341127	CHEMBL1826699	Activity of RPS6KA4(Kin.Dom.1-N-terminal) kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL3125	Homo sapiens	Activity	%	100.0
	6341128	CHEMBL1826700	Activity of RPS6KA4(Kin.Dom.2-C-terminal) kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL3125	Homo sapiens	Activity	%	100.0
	7567200	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7567325	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7567659	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7567784	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7568130	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7568281	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7568598	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7568713	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	2000.0	CHEMBL3125	Homo sapiens	Kd	nM	2000.0
	7569173	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7569298	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7569633	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7569758	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7569788	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7570105	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7570251	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7570553	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	96.0	CHEMBL3125	Homo sapiens	Kd	nM	96.0
	7570678	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	2000.0	CHEMBL3125	Homo sapiens	Kd	nM	2000.0
	7571149	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7571274	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	12.0	CHEMBL3125	Homo sapiens	Kd	nM	12.0
	7571606	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7571765	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	340.0	CHEMBL3125	Homo sapiens	Kd	nM	340.0
	7572103	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7572228	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7572519	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	2500.0	CHEMBL3125	Homo sapiens	Kd	nM	2500.0
	7572644	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7573130	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	620.0	CHEMBL3125	Homo sapiens	Kd	nM	620.0
	7573270	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7573587	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7573621	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	3200.0	CHEMBL3125	Homo sapiens	Kd	nM	3200.0
	7573746	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7574090	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	260.0	CHEMBL3125	Homo sapiens	Kd	nM	260.0
	7574215	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7574498	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7574623	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7574791	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7575108	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7575252	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	7000.0	CHEMBL3125	Homo sapiens	Kd	nM	7000.0
	7575598	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7575723	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7576063	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7576188	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7576471	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7576596	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	140.0	CHEMBL3125	Homo sapiens	Kd	nM	140.0
	7576765	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7577099	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7577224	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7577577	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	2200.0	CHEMBL3125	Homo sapiens	Kd	nM	2200.0
	7577702	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	1100.0	CHEMBL3125	Homo sapiens	Kd	nM	1100.0
	7578047	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7578172	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	65.0	CHEMBL3125	Homo sapiens	Kd	nM	65.0
	7578452	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7578577	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7578648	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7578773	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	3200.0	CHEMBL3125	Homo sapiens	Kd	nM	3200.0
	7579022	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7579147	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7579472	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	1300.0	CHEMBL3125	Homo sapiens	Kd	nM	1300.0
	7579597	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7579946	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7580071	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7580415	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7580818	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7581006	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7581131	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7581391	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7581516	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Kd	nM	2300.0	CHEMBL3125	Homo sapiens	Kd	nM	2300.0
	7581836	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7581961	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7582307	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	=	Kd	nM	2500.0	CHEMBL3125	Homo sapiens	Kd	nM	2500.0
	7582432	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7582454	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7582771	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7582854	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7583171	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7583352	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	7200.0	CHEMBL3125	Homo sapiens	Kd	nM	7200.0
	7583477	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7583749	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7583874	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7584194	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7584319	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7584665	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	6100.0	CHEMBL3125	Homo sapiens	Kd	nM	6100.0
	7584810	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	44.0	CHEMBL3125	Homo sapiens	Kd	nM	44.0
	7585127	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7585214	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7585682	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7585807	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7586090	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7586215	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7586536	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7586690	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7587007	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7587144	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7587643	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7587768	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7588062	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	62.0	CHEMBL3125	Homo sapiens	Kd	nM	62.0
	7588198	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	1200.0	CHEMBL3125	Homo sapiens	Kd	nM	1200.0
	7588515	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7588669	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7588995	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7589120	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7589608	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7589715	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	1300.0	CHEMBL3125	Homo sapiens	Kd	nM	1300.0
	7590032	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	590.0	CHEMBL3125	Homo sapiens	Kd	nM	590.0
	7590182	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7590531	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7590656	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7590982	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7591107	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7591264	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7591581	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	1900.0	CHEMBL3125	Homo sapiens	Kd	nM	1900.0
	7591686	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7592003	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7592033	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7592158	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	=	Kd	nM	740.0	CHEMBL3125	Homo sapiens	Kd	nM	740.0
	7592506	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7592631	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7592959	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7593084	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7593231	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7593548	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7593666	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7594013	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7594138	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	51.0	CHEMBL3125	Homo sapiens	Kd	nM	51.0
	7594486	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7594611	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7594938	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7595063	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7595199	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7595518	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7595643	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7595992	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7596117	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7596463	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7596588	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7596910	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	120.0	CHEMBL3125	Homo sapiens	Kd	nM	120.0
	7597046	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7597171	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7597499	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7597624	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7597972	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7598097	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7598442	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL3125	Homo sapiens	Kd	nM	10000.0
	7598567	CHEMBL1908624	Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	2200.0	CHEMBL3125	Homo sapiens	Kd	nM	2200.0
	7598884	CHEMBL1908503	Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	200.0	CHEMBL3125	Homo sapiens	Kd	nM	200.0
	7922682	CHEMBL1918464	Inhibition of human recombinant MSK2 at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	49.0	CHEMBL3125	Homo sapiens	INH	%	49.0
	7961065	CHEMBL1931514	Inhibition of MSK2	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL3125	Homo sapiens	IC50	uM	30.0
	7961066	CHEMBL1931514	Inhibition of MSK2	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL3125	Homo sapiens	IC50	uM	30.0
	7970443	CHEMBL1929916	Inhibition of MSK2 at 10 uM	B	NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL1929247	=	Inhibition	%	3.0	CHEMBL3125	Homo sapiens	INH	%	3.0
	7996762	CHEMBL1944079	Inhibition of RPS6KA4 (Kin.Dom.1) at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939492	=	Inhibition	%	92.0	CHEMBL3125	Homo sapiens	INH	%	92.0
	8004505	CHEMBL1943937	Inhibition of RPS6KA4 at 1 uM	B	O=c1c2ccccc2[se]n1-c1ccccc1		CHEMBL51085	=	Inhibition	%	0.0	CHEMBL3125	Homo sapiens	INH	%	0.0
	8004549	CHEMBL1943937	Inhibition of RPS6KA4 at 1 uM	B	CC(=O)OC[C@H]1O[C@@H](O[C@H]2[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](n3[se]c4ccccc4c3=O)O[C@@H]2COC(C)=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H]1OC(C)=O		CHEMBL1940993	=	Inhibition	%	0.0	CHEMBL3125	Homo sapiens	INH	%	0.0
	8005213	CHEMBL1943937	Inhibition of RPS6KA4 at 1 uM	B	CC(=O)OC[C@H]1O[C@@H](NC(=O)CCCn2[se]c3ccccc3c2=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O		CHEMBL1940997	=	Inhibition	%	0.0	CHEMBL3125	Homo sapiens	INH	%	0.0
	8005256	CHEMBL1943937	Inhibition of RPS6KA4 at 1 uM	B	O=C(CCCn1[se]c2ccccc2c1=O)N[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O		CHEMBL1940999	=	Inhibition	%	0.0	CHEMBL3125	Homo sapiens	INH	%	0.0
	8061226	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-0.59	CHEMBL3125	Homo sapiens	Inhibition	%	-0.59
	8061403	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	4.49	CHEMBL3125	Homo sapiens	Inhibition	%	4.49
	8061627	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	0.22	CHEMBL3125	Homo sapiens	Inhibition	%	0.22
	8061734	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	3.56	CHEMBL3125	Homo sapiens	Inhibition	%	3.56
	8062149	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	10.11	CHEMBL3125	Homo sapiens	Inhibition	%	10.11
	8062265	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	7.86	CHEMBL3125	Homo sapiens	Inhibition	%	7.86
	8062651	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	3.95	CHEMBL3125	Homo sapiens	Inhibition	%	3.95
	8062973	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-1.34	CHEMBL3125	Homo sapiens	Inhibition	%	-1.34
	8063105	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	2.82	CHEMBL3125	Homo sapiens	Inhibition	%	2.82
	8063496	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.02	CHEMBL3125	Homo sapiens	Inhibition	%	2.02
	8063604	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.14	CHEMBL3125	Homo sapiens	Inhibition	%	2.14
	8063828	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	4.23	CHEMBL3125	Homo sapiens	Inhibition	%	4.23
	8064010	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	0.3	CHEMBL3125	Homo sapiens	Inhibition	%	0.3
	8064125	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	39.63	CHEMBL3125	Homo sapiens	Inhibition	%	39.63
	8064349	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	61.21	CHEMBL3125	Homo sapiens	Inhibition	%	61.21
	8064559	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	2.41	CHEMBL3125	Homo sapiens	Inhibition	%	2.41
	8064697	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	1.03	CHEMBL3125	Homo sapiens	Inhibition	%	1.03
	8064921	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	4.59	CHEMBL3125	Homo sapiens	Inhibition	%	4.59
	8065087	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	2.27	CHEMBL3125	Homo sapiens	Inhibition	%	2.27
	8065427	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	2.29	CHEMBL3125	Homo sapiens	Inhibition	%	2.29
	8065602	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	3.51	CHEMBL3125	Homo sapiens	Inhibition	%	3.51
	8065941	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	79.01	CHEMBL3125	Homo sapiens	Inhibition	%	79.01
	8066151	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	2.18	CHEMBL3125	Homo sapiens	Inhibition	%	2.18
	8066511	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	2.85	CHEMBL3125	Homo sapiens	Inhibition	%	2.85
	8066677	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	2.9	CHEMBL3125	Homo sapiens	Inhibition	%	2.9
	8067025	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	2.39	CHEMBL3125	Homo sapiens	Inhibition	%	2.39
	8067200	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.77	CHEMBL3125	Homo sapiens	Inhibition	%	0.77
	8067545	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	5.06	CHEMBL3125	Homo sapiens	Inhibition	%	5.06
	8067755	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	19.54	CHEMBL3125	Homo sapiens	Inhibition	%	19.54
	8068114	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	15.73	CHEMBL3125	Homo sapiens	Inhibition	%	15.73
	8068278	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.0	CHEMBL3125	Homo sapiens	Inhibition	%	1.0
	8068502	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.71	CHEMBL3125	Homo sapiens	Inhibition	%	2.71
	8068627	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.1	CHEMBL3125	Homo sapiens	Inhibition	%	0.1
	8068801	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	4.31	CHEMBL3125	Homo sapiens	Inhibition	%	4.31
	8069025	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	1.31	CHEMBL3125	Homo sapiens	Inhibition	%	1.31
	8069150	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	6.2	CHEMBL3125	Homo sapiens	Inhibition	%	6.2
	8069445	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	1.59	CHEMBL3125	Homo sapiens	Inhibition	%	1.59
	8069830	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.85	CHEMBL3125	Homo sapiens	Inhibition	%	2.85
	8069956	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	2.25	CHEMBL3125	Homo sapiens	Inhibition	%	2.25
	8070352	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	4.13	CHEMBL3125	Homo sapiens	Inhibition	%	4.13
	8070477	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.53	CHEMBL3125	Homo sapiens	Inhibition	%	1.53
	8070701	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	2.87	CHEMBL3125	Homo sapiens	Inhibition	%	2.87
	8070775	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	7.3	CHEMBL3125	Homo sapiens	Inhibition	%	7.3
	8071156	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	3.47	CHEMBL3125	Homo sapiens	Inhibition	%	3.47
	8071282	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	1.84	CHEMBL3125	Homo sapiens	Inhibition	%	1.84
	8071506	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.64	CHEMBL3125	Homo sapiens	Inhibition	%	0.64
	8071679	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	0.7	CHEMBL3125	Homo sapiens	Inhibition	%	0.7
	8072028	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	1.67	CHEMBL3125	Homo sapiens	Inhibition	%	1.67
	8072109	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-1.41	CHEMBL3125	Homo sapiens	Inhibition	%	-1.41
	8072118	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-0.69	CHEMBL3125	Homo sapiens	Inhibition	%	-0.69
	8072342	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.7	CHEMBL3125	Homo sapiens	Inhibition	%	1.7
	8072499	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	2.62	CHEMBL3125	Homo sapiens	Inhibition	%	2.62
	8072848	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.13	CHEMBL3125	Homo sapiens	Inhibition	%	0.13
	8073015	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.64	CHEMBL3125	Homo sapiens	Inhibition	%	2.64
	8073364	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	2.86	CHEMBL3125	Homo sapiens	Inhibition	%	2.86
	8073707	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	2.32	CHEMBL3125	Homo sapiens	Inhibition	%	2.32
	8073940	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	2.0	CHEMBL3125	Homo sapiens	Inhibition	%	2.0
	8074092	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	3.88	CHEMBL3125	Homo sapiens	Inhibition	%	3.88
	8074446	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.89	CHEMBL3125	Homo sapiens	Inhibition	%	0.89
	8074603	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	-1.39	CHEMBL3125	Homo sapiens	Inhibition	%	-1.39
	8074827	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.64	CHEMBL3125	Homo sapiens	Inhibition	%	1.64
	8074954	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	1.01	CHEMBL3125	Homo sapiens	Inhibition	%	1.01
	8075289	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.3	CHEMBL3125	Homo sapiens	Inhibition	%	0.3
	8075526	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	6.06	CHEMBL3125	Homo sapiens	Inhibition	%	6.06
	8075667	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	2.51	CHEMBL3125	Homo sapiens	Inhibition	%	2.51
	8075891	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	2.85	CHEMBL3125	Homo sapiens	Inhibition	%	2.85
	8076033	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.7	CHEMBL3125	Homo sapiens	Inhibition	%	0.7
	8076405	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	0.49	CHEMBL3125	Homo sapiens	Inhibition	%	0.49
	8076539	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	2.7	CHEMBL3125	Homo sapiens	Inhibition	%	2.7
	8076865	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.33	CHEMBL3125	Homo sapiens	Inhibition	%	0.33
	8077112	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	15.03	CHEMBL3125	Homo sapiens	Inhibition	%	15.03
	8077464	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	0.19	CHEMBL3125	Homo sapiens	Inhibition	%	0.19
	8077615	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	2.33	CHEMBL3125	Homo sapiens	Inhibition	%	2.33
	8077982	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	0.9	CHEMBL3125	Homo sapiens	Inhibition	%	0.9
	8078121	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-0.21	CHEMBL3125	Homo sapiens	Inhibition	%	-0.21
	8078345	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	8.93	CHEMBL3125	Homo sapiens	Inhibition	%	8.93
	8078447	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-0.82	CHEMBL3125	Homo sapiens	Inhibition	%	-0.82
	8078697	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	61.31	CHEMBL3125	Homo sapiens	Inhibition	%	61.31
	8079037	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.28	CHEMBL3125	Homo sapiens	Inhibition	%	2.28
	8079195	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.35	CHEMBL3125	Homo sapiens	Inhibition	%	0.35
	8079419	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	1.7	CHEMBL3125	Homo sapiens	Inhibition	%	1.7
	8079561	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	-0.07	CHEMBL3125	Homo sapiens	Inhibition	%	-0.07
	8079924	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	2.82	CHEMBL3125	Homo sapiens	Inhibition	%	2.82
	8080029	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	1.3	CHEMBL3125	Homo sapiens	Inhibition	%	1.3
	8080253	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.07	CHEMBL3125	Homo sapiens	Inhibition	%	0.07
	8080281	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	5.45	CHEMBL3125	Homo sapiens	Inhibition	%	5.45
	8080505	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	20.9	CHEMBL3125	Homo sapiens	Inhibition	%	20.9
	8080620	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	-3.48	CHEMBL3125	Homo sapiens	Inhibition	%	-3.48
	8081008	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-1.86	CHEMBL3125	Homo sapiens	Inhibition	%	-1.86
	8081143	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	2.42	CHEMBL3125	Homo sapiens	Inhibition	%	2.42
	8081367	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.75	CHEMBL3125	Homo sapiens	Inhibition	%	1.75
	8081511	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	12.03	CHEMBL3125	Homo sapiens	Inhibition	%	12.03
	8081838	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	3.61	CHEMBL3125	Homo sapiens	Inhibition	%	3.61
	8082090	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	59.65	CHEMBL3125	Homo sapiens	Inhibition	%	59.65
	8082203	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.47	CHEMBL3125	Homo sapiens	Inhibition	%	1.47
	8082427	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	0.42	CHEMBL3125	Homo sapiens	Inhibition	%	0.42
	8082600	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-1.17	CHEMBL3125	Homo sapiens	Inhibition	%	-1.17
	8082947	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	3.11	CHEMBL3125	Homo sapiens	Inhibition	%	3.11
	8083103	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	3.85	CHEMBL3125	Homo sapiens	Inhibition	%	3.85
	8083426	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.62	CHEMBL3125	Homo sapiens	Inhibition	%	0.62
	8083680	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	82.97	CHEMBL3125	Homo sapiens	Inhibition	%	82.97
	8084014	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	3.67	CHEMBL3125	Homo sapiens	Inhibition	%	3.67
	8084199	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	20.39	CHEMBL3125	Homo sapiens	Inhibition	%	20.39
	8084541	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.42	CHEMBL3125	Homo sapiens	Inhibition	%	2.42
	8084702	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	13.65	CHEMBL3125	Homo sapiens	Inhibition	%	13.65
	8085024	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	2.85	CHEMBL3125	Homo sapiens	Inhibition	%	2.85
	8085280	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	1.75	CHEMBL3125	Homo sapiens	Inhibition	%	1.75
	8085612	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	1.72	CHEMBL3125	Homo sapiens	Inhibition	%	1.72
	8085801	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	61.19	CHEMBL3125	Homo sapiens	Inhibition	%	61.19
	8086025	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	2.56	CHEMBL3125	Homo sapiens	Inhibition	%	2.56
	8086140	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	6.24	CHEMBL3125	Homo sapiens	Inhibition	%	6.24
	8086302	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	2.85	CHEMBL3125	Homo sapiens	Inhibition	%	2.85
	8086526	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	5.51	CHEMBL3125	Homo sapiens	Inhibition	%	5.51
	8086625	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.33	CHEMBL3125	Homo sapiens	Inhibition	%	0.33
	8086849	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	2.82	CHEMBL3125	Homo sapiens	Inhibition	%	2.82
	8087060	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	3.75	CHEMBL3125	Homo sapiens	Inhibition	%	3.75
	8087218	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	1.96	CHEMBL3125	Homo sapiens	Inhibition	%	1.96
	8087556	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	4.65	CHEMBL3125	Homo sapiens	Inhibition	%	4.65
	8087694	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.25	CHEMBL3125	Homo sapiens	Inhibition	%	1.25
	8087918	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.09	CHEMBL3125	Homo sapiens	Inhibition	%	1.09
	8088060	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	4.71	CHEMBL3125	Homo sapiens	Inhibition	%	4.71
	8088432	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.34	CHEMBL3125	Homo sapiens	Inhibition	%	0.34
	8088560	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	4.79	CHEMBL3125	Homo sapiens	Inhibition	%	4.79
	8088877	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	40.35	CHEMBL3125	Homo sapiens	Inhibition	%	40.35
	8089229	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	1.99	CHEMBL3125	Homo sapiens	Inhibition	%	1.99
	8089377	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	2.65	CHEMBL3125	Homo sapiens	Inhibition	%	2.65
	8089721	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.38	CHEMBL3125	Homo sapiens	Inhibition	%	0.38
	8089901	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-1.94	CHEMBL3125	Homo sapiens	Inhibition	%	-1.94
	8090125	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.13	CHEMBL3125	Homo sapiens	Inhibition	%	0.13
	8090290	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	3.9	CHEMBL3125	Homo sapiens	Inhibition	%	3.9
	8090457	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.47	CHEMBL3125	Homo sapiens	Inhibition	%	2.47
	8090820	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	2.0	CHEMBL3125	Homo sapiens	Inhibition	%	2.0
	8091025	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.06	CHEMBL3125	Homo sapiens	Inhibition	%	3.06
	8091386	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	1.37	CHEMBL3125	Homo sapiens	Inhibition	%	1.37
	8091541	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	2.63	CHEMBL3125	Homo sapiens	Inhibition	%	2.63
	8091765	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	1.21	CHEMBL3125	Homo sapiens	Inhibition	%	1.21
	8091881	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	2.42	CHEMBL3125	Homo sapiens	Inhibition	%	2.42
	8092242	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	0.21	CHEMBL3125	Homo sapiens	Inhibition	%	0.21
	8092393	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	3.41	CHEMBL3125	Homo sapiens	Inhibition	%	3.41
	8092765	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.59	CHEMBL3125	Homo sapiens	Inhibition	%	1.59
	8092894	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	5.46	CHEMBL3125	Homo sapiens	Inhibition	%	5.46
	8093118	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	3.9	CHEMBL3125	Homo sapiens	Inhibition	%	3.9
	8093206	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	2.6	CHEMBL3125	Homo sapiens	Inhibition	%	2.6
	8093570	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	1.92	CHEMBL3125	Homo sapiens	Inhibition	%	1.92
	8093709	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	15.93	CHEMBL3125	Homo sapiens	Inhibition	%	15.93
	8093933	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	1.24	CHEMBL3125	Homo sapiens	Inhibition	%	1.24
	8094053	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.77	CHEMBL3125	Homo sapiens	Inhibition	%	1.77
	8094457	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.02	CHEMBL3125	Homo sapiens	Inhibition	%	1.02
	8094632	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	1.8	CHEMBL3125	Homo sapiens	Inhibition	%	1.8
	8094788	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	3.6	CHEMBL3125	Homo sapiens	Inhibition	%	3.6
	8095012	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.52	CHEMBL3125	Homo sapiens	Inhibition	%	2.52
	8095152	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	4.78	CHEMBL3125	Homo sapiens	Inhibition	%	4.78
	8095355	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.56	CHEMBL3125	Homo sapiens	Inhibition	%	2.56
	8095579	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.92	CHEMBL3125	Homo sapiens	Inhibition	%	0.92
	8095720	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	5.28	CHEMBL3125	Homo sapiens	Inhibition	%	5.28
	8096092	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	2.89	CHEMBL3125	Homo sapiens	Inhibition	%	2.89
	8096209	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	3.47	CHEMBL3125	Homo sapiens	Inhibition	%	3.47
	8096433	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	1.93	CHEMBL3125	Homo sapiens	Inhibition	%	1.93
	8096572	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-0.52	CHEMBL3125	Homo sapiens	Inhibition	%	-0.52
	8096728	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	4.94	CHEMBL3125	Homo sapiens	Inhibition	%	4.94
	8096952	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	2.85	CHEMBL3125	Homo sapiens	Inhibition	%	2.85
	8097099	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.29	CHEMBL3125	Homo sapiens	Inhibition	%	1.29
	8097406	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	5.75	CHEMBL3125	Homo sapiens	Inhibition	%	5.75
	8097630	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	2.85	CHEMBL3125	Homo sapiens	Inhibition	%	2.85
	8097780	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	19.71	CHEMBL3125	Homo sapiens	Inhibition	%	19.71
	8098137	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	2.84	CHEMBL3125	Homo sapiens	Inhibition	%	2.84
	8098257	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	1.36	CHEMBL3125	Homo sapiens	Inhibition	%	1.36
	8098481	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.28	CHEMBL3125	Homo sapiens	Inhibition	%	-0.28
	8098661	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.09	CHEMBL3125	Homo sapiens	Inhibition	%	2.09
	8098846	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	7.26	CHEMBL3125	Homo sapiens	Inhibition	%	7.26
	8099214	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.49	CHEMBL3125	Homo sapiens	Inhibition	%	3.49
	8099356	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.45	CHEMBL3125	Homo sapiens	Inhibition	%	1.45
	8099580	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	3.01	CHEMBL3125	Homo sapiens	Inhibition	%	3.01
	8099774	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-0.56	CHEMBL3125	Homo sapiens	Inhibition	%	-0.56
	8099921	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	3.45	CHEMBL3125	Homo sapiens	Inhibition	%	3.45
	8100291	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	0.74	CHEMBL3125	Homo sapiens	Inhibition	%	0.74
	8100631	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	3.03	CHEMBL3125	Homo sapiens	Inhibition	%	3.03
	8100771	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.11	CHEMBL3125	Homo sapiens	Inhibition	%	0.11
	8101155	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	5.28	CHEMBL3125	Homo sapiens	Inhibition	%	5.28
	8101297	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-1.71	CHEMBL3125	Homo sapiens	Inhibition	%	-1.71
	8101706	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	2.99	CHEMBL3125	Homo sapiens	Inhibition	%	2.99
	8101959	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	4.13	CHEMBL3125	Homo sapiens	Inhibition	%	4.13
	8102114	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-1.85	CHEMBL3125	Homo sapiens	Inhibition	%	-1.85
	8102469	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	0.54	CHEMBL3125	Homo sapiens	Inhibition	%	0.54
	8102813	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.02	CHEMBL3125	Homo sapiens	Inhibition	%	1.02
	8102991	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.67	CHEMBL3125	Homo sapiens	Inhibition	%	1.67
	8103187	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	3.75	CHEMBL3125	Homo sapiens	Inhibition	%	3.75
	8103411	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	20.5	CHEMBL3125	Homo sapiens	Inhibition	%	20.5
	8103549	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.68	CHEMBL3125	Homo sapiens	Inhibition	%	0.68
	8103923	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	3.06	CHEMBL3125	Homo sapiens	Inhibition	%	3.06
	8104108	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.82	CHEMBL3125	Homo sapiens	Inhibition	%	0.82
	8104256	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	5.55	CHEMBL3125	Homo sapiens	Inhibition	%	5.55
	8104480	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	3.23	CHEMBL3125	Homo sapiens	Inhibition	%	3.23
	8104626	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	3.26	CHEMBL3125	Homo sapiens	Inhibition	%	3.26
	8104964	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	1.76	CHEMBL3125	Homo sapiens	Inhibition	%	1.76
	8105104	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.6	CHEMBL3125	Homo sapiens	Inhibition	%	0.6
	8105328	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.3	CHEMBL3125	Homo sapiens	Inhibition	%	0.3
	8105494	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	2.84	CHEMBL3125	Homo sapiens	Inhibition	%	2.84
	8105632	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	0.02	CHEMBL3125	Homo sapiens	Inhibition	%	0.02
	8105856	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	2.85	CHEMBL3125	Homo sapiens	Inhibition	%	2.85
	8105912	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.16	CHEMBL3125	Homo sapiens	Inhibition	%	1.16
	8106136	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	2.5	CHEMBL3125	Homo sapiens	Inhibition	%	2.5
	8106301	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	1.95	CHEMBL3125	Homo sapiens	Inhibition	%	1.95
	8106457	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	1.24	CHEMBL3125	Homo sapiens	Inhibition	%	1.24
	8106681	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	12.94	CHEMBL3125	Homo sapiens	Inhibition	%	12.94
	8106810	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	1.06	CHEMBL3125	Homo sapiens	Inhibition	%	1.06
	8107155	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.39	CHEMBL3125	Homo sapiens	Inhibition	%	0.39
	8107327	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.32	CHEMBL3125	Homo sapiens	Inhibition	%	2.32
	8107752	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	1.23	CHEMBL3125	Homo sapiens	Inhibition	%	1.23
	8107887	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	1.21	CHEMBL3125	Homo sapiens	Inhibition	%	1.21
	8108269	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	2.24	CHEMBL3125	Homo sapiens	Inhibition	%	2.24
	8108444	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-0.55	CHEMBL3125	Homo sapiens	Inhibition	%	-0.55
	8108815	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	7.58	CHEMBL3125	Homo sapiens	Inhibition	%	7.58
	8108957	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-0.78	CHEMBL3125	Homo sapiens	Inhibition	%	-0.78
	8109181	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.33	CHEMBL3125	Homo sapiens	Inhibition	%	0.33
	8109295	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	2.54	CHEMBL3125	Homo sapiens	Inhibition	%	2.54
	8109649	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.62	CHEMBL3125	Homo sapiens	Inhibition	%	-1.62
	8109820	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	5.67	CHEMBL3125	Homo sapiens	Inhibition	%	5.67
	8110176	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	2.84	CHEMBL3125	Homo sapiens	Inhibition	%	2.84
	8110455	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.19	CHEMBL3125	Homo sapiens	Inhibition	%	1.19
	8110621	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	4.5	CHEMBL3125	Homo sapiens	Inhibition	%	4.5
	8111003	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	51.95	CHEMBL3125	Homo sapiens	Inhibition	%	51.95
	8111126	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.22	CHEMBL3125	Homo sapiens	Inhibition	%	1.22
	8111350	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.3	CHEMBL3125	Homo sapiens	Inhibition	%	1.3
	8111477	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	3.2	CHEMBL3125	Homo sapiens	Inhibition	%	3.2
	8111643	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.32	CHEMBL3125	Homo sapiens	Inhibition	%	1.32
	8111867	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	1.15	CHEMBL3125	Homo sapiens	Inhibition	%	1.15
	8112072	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	8.07	CHEMBL3125	Homo sapiens	Inhibition	%	8.07
	8112209	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.44	CHEMBL3125	Homo sapiens	Inhibition	%	0.44
	8112433	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.3	CHEMBL3125	Homo sapiens	Inhibition	%	0.3
	8112601	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	3.08	CHEMBL3125	Homo sapiens	Inhibition	%	3.08
	8112773	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.88	CHEMBL3125	Homo sapiens	Inhibition	%	0.88
	8112997	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-1.22	CHEMBL3125	Homo sapiens	Inhibition	%	-1.22
	8113149	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.16	CHEMBL3125	Homo sapiens	Inhibition	%	3.16
	8113509	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.04	CHEMBL3125	Homo sapiens	Inhibition	%	0.04
	8113633	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	2.03	CHEMBL3125	Homo sapiens	Inhibition	%	2.03
	8113973	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.85	CHEMBL3125	Homo sapiens	Inhibition	%	-1.85
	8114149	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	1.66	CHEMBL3125	Homo sapiens	Inhibition	%	1.66
	8114373	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	2.03	CHEMBL3125	Homo sapiens	Inhibition	%	2.03
	8114505	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	2.45	CHEMBL3125	Homo sapiens	Inhibition	%	2.45
	8114781	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.43	CHEMBL3125	Homo sapiens	Inhibition	%	2.43
	8114947	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	3.23	CHEMBL3125	Homo sapiens	Inhibition	%	3.23
	8115171	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	19.67	CHEMBL3125	Homo sapiens	Inhibition	%	19.67
	8115336	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	2.79	CHEMBL3125	Homo sapiens	Inhibition	%	2.79
	8115680	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.32	CHEMBL3125	Homo sapiens	Inhibition	%	1.32
	8115813	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	17.49	CHEMBL3125	Homo sapiens	Inhibition	%	17.49
	8116196	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	6.02	CHEMBL3125	Homo sapiens	Inhibition	%	6.02
	8116399	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	3.66	CHEMBL3125	Homo sapiens	Inhibition	%	3.66
	8116757	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.04	CHEMBL3125	Homo sapiens	Inhibition	%	0.04
	8116929	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	2.86	CHEMBL3125	Homo sapiens	Inhibition	%	2.86
	8117324	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.37	CHEMBL3125	Homo sapiens	Inhibition	%	0.37
	8117482	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	9.93	CHEMBL3125	Homo sapiens	Inhibition	%	9.93
	8117836	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	1.73	CHEMBL3125	Homo sapiens	Inhibition	%	1.73
	8117974	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	3.37	CHEMBL3125	Homo sapiens	Inhibition	%	3.37
	8118198	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	4.69	CHEMBL3125	Homo sapiens	Inhibition	%	4.69
	8118314	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.65	CHEMBL3125	Homo sapiens	Inhibition	%	3.65
	8118710	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	4.21	CHEMBL3125	Homo sapiens	Inhibition	%	4.21
	8118846	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	1.61	CHEMBL3125	Homo sapiens	Inhibition	%	1.61
	8119117	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	-0.16	CHEMBL3125	Homo sapiens	Inhibition	%	-0.16
	8119500	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	1.6	CHEMBL3125	Homo sapiens	Inhibition	%	1.6
	8119667	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	4.81	CHEMBL3125	Homo sapiens	Inhibition	%	4.81
	8120010	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.96	CHEMBL3125	Homo sapiens	Inhibition	%	1.96
	8120149	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.87	CHEMBL3125	Homo sapiens	Inhibition	%	0.87
	8120373	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	2.08	CHEMBL3125	Homo sapiens	Inhibition	%	2.08
	8120533	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.14	CHEMBL3125	Homo sapiens	Inhibition	%	0.14
	8120734	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	14.91	CHEMBL3125	Homo sapiens	Inhibition	%	14.91
	8121086	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-1.31	CHEMBL3125	Homo sapiens	Inhibition	%	-1.31
	8121258	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	3.21	CHEMBL3125	Homo sapiens	Inhibition	%	3.21
	8121482	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	3.94	CHEMBL3125	Homo sapiens	Inhibition	%	3.94
	8121649	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	2.61	CHEMBL3125	Homo sapiens	Inhibition	%	2.61
	8121812	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	2.12	CHEMBL3125	Homo sapiens	Inhibition	%	2.12
	8122036	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	4.72	CHEMBL3125	Homo sapiens	Inhibition	%	4.72
	8122157	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-1.15	CHEMBL3125	Homo sapiens	Inhibition	%	-1.15
	8122519	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	15.31	CHEMBL3125	Homo sapiens	Inhibition	%	15.31
	8122639	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	5.79	CHEMBL3125	Homo sapiens	Inhibition	%	5.79
	8123030	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	4.3	CHEMBL3125	Homo sapiens	Inhibition	%	4.3
	8123172	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	2.52	CHEMBL3125	Homo sapiens	Inhibition	%	2.52
	8123396	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	5.14	CHEMBL3125	Homo sapiens	Inhibition	%	5.14
	8123450	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	2.07	CHEMBL3125	Homo sapiens	Inhibition	%	2.07
	8123674	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.96	CHEMBL3125	Homo sapiens	Inhibition	%	0.96
	8123824	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	4.55	CHEMBL3125	Homo sapiens	Inhibition	%	4.55
	8123991	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	2.44	CHEMBL3125	Homo sapiens	Inhibition	%	2.44
	8124215	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	3.95	CHEMBL3125	Homo sapiens	Inhibition	%	3.95
	8124334	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	1.62	CHEMBL3125	Homo sapiens	Inhibition	%	1.62
	8124697	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	2.64	CHEMBL3125	Homo sapiens	Inhibition	%	2.64
	8124862	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.97	CHEMBL3125	Homo sapiens	Inhibition	%	-0.97
	8125063	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.19	CHEMBL3125	Homo sapiens	Inhibition	%	3.19
	8125287	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	5.69	CHEMBL3125	Homo sapiens	Inhibition	%	5.69
	8125417	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.31	CHEMBL3125	Homo sapiens	Inhibition	%	-0.31
	8125809	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.33	CHEMBL3125	Homo sapiens	Inhibition	%	2.33
	8125973	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.41	CHEMBL3125	Homo sapiens	Inhibition	%	0.41
	8126361	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	2.43	CHEMBL3125	Homo sapiens	Inhibition	%	2.43
	8126476	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	6.99	CHEMBL3125	Homo sapiens	Inhibition	%	6.99
	8126836	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	50.85	CHEMBL3125	Homo sapiens	Inhibition	%	50.85
	8126958	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.53	CHEMBL3125	Homo sapiens	Inhibition	%	2.53
	8127182	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	5.09	CHEMBL3125	Homo sapiens	Inhibition	%	5.09
	8127349	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	4.36	CHEMBL3125	Homo sapiens	Inhibition	%	4.36
	8127715	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	3.31	CHEMBL3125	Homo sapiens	Inhibition	%	3.31
	8128003	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	2.98	CHEMBL3125	Homo sapiens	Inhibition	%	2.98
	8128155	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.39	CHEMBL3125	Homo sapiens	Inhibition	%	1.39
	8128546	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.83	CHEMBL3125	Homo sapiens	Inhibition	%	1.83
	8128665	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	10.51	CHEMBL3125	Homo sapiens	Inhibition	%	10.51
	8128889	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	1.14	CHEMBL3125	Homo sapiens	Inhibition	%	1.14
	8129026	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.45	CHEMBL3125	Homo sapiens	Inhibition	%	1.45
	8129197	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.1	CHEMBL3125	Homo sapiens	Inhibition	%	0.1
	8129421	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-2.21	CHEMBL3125	Homo sapiens	Inhibition	%	-2.21
	8129610	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	2.61	CHEMBL3125	Homo sapiens	Inhibition	%	2.61
	8129749	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.76	CHEMBL3125	Homo sapiens	Inhibition	%	0.76
	8129973	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.05	CHEMBL3125	Homo sapiens	Inhibition	%	-0.05
	8130134	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.58	CHEMBL3125	Homo sapiens	Inhibition	%	1.58
	8130306	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.26	CHEMBL3125	Homo sapiens	Inhibition	%	0.26
	8130690	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	7.32	CHEMBL3125	Homo sapiens	Inhibition	%	7.32
	8130806	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	2.75	CHEMBL3125	Homo sapiens	Inhibition	%	2.75
	8131030	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.09	CHEMBL3125	Homo sapiens	Inhibition	%	1.09
	8131169	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	3.92	CHEMBL3125	Homo sapiens	Inhibition	%	3.92
	8131513	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	1.95	CHEMBL3125	Homo sapiens	Inhibition	%	1.95
	8131680	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	5.01	CHEMBL3125	Homo sapiens	Inhibition	%	5.01
	8132045	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	20.82	CHEMBL3125	Homo sapiens	Inhibition	%	20.82
	8132331	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	1.07	CHEMBL3125	Homo sapiens	Inhibition	%	1.07
	8132478	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	2.46	CHEMBL3125	Homo sapiens	Inhibition	%	2.46
	8132702	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	7.4	CHEMBL3125	Homo sapiens	Inhibition	%	7.4
	8132870	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.78	CHEMBL3125	Homo sapiens	Inhibition	%	1.78
	8133215	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	1.71	CHEMBL3125	Homo sapiens	Inhibition	%	1.71
	8133353	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.22	CHEMBL3125	Homo sapiens	Inhibition	%	2.22
	8133749	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.11	CHEMBL3125	Homo sapiens	Inhibition	%	-1.11
	8133929	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	13.81	CHEMBL3125	Homo sapiens	Inhibition	%	13.81
	8134301	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.35	CHEMBL3125	Homo sapiens	Inhibition	%	-0.35
	8134461	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.78	CHEMBL3125	Homo sapiens	Inhibition	%	1.78
	8134645	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-0.53	CHEMBL3125	Homo sapiens	Inhibition	%	-0.53
	8134869	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	7.44	CHEMBL3125	Homo sapiens	Inhibition	%	7.44
	8135029	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	0.46	CHEMBL3125	Homo sapiens	Inhibition	%	0.46
	8135368	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	1.86	CHEMBL3125	Homo sapiens	Inhibition	%	1.86
	8135509	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	6.31	CHEMBL3125	Homo sapiens	Inhibition	%	6.31
	8135733	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	3.38	CHEMBL3125	Homo sapiens	Inhibition	%	3.38
	8135854	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	4.12	CHEMBL3125	Homo sapiens	Inhibition	%	4.12
	8136022	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.48	CHEMBL3125	Homo sapiens	Inhibition	%	2.48
	8136246	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.78	CHEMBL3125	Homo sapiens	Inhibition	%	2.78
	8136390	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	3.63	CHEMBL3125	Homo sapiens	Inhibition	%	3.63
	8136680	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	2.79	CHEMBL3125	Homo sapiens	Inhibition	%	2.79
	8137039	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	39.09	CHEMBL3125	Homo sapiens	Inhibition	%	39.09
	8137202	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	1.74	CHEMBL3125	Homo sapiens	Inhibition	%	1.74
	8137546	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	1.35	CHEMBL3125	Homo sapiens	Inhibition	%	1.35
	8137694	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.55	CHEMBL3125	Homo sapiens	Inhibition	%	1.55
	8138084	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.35	CHEMBL3125	Homo sapiens	Inhibition	%	-0.35
	8138263	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.54	CHEMBL3125	Homo sapiens	Inhibition	%	1.54
	8138635	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-1.65	CHEMBL3125	Homo sapiens	Inhibition	%	-1.65
	8138793	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-0.44	CHEMBL3125	Homo sapiens	Inhibition	%	-0.44
	8139202	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	2.87	CHEMBL3125	Homo sapiens	Inhibition	%	2.87
	8139361	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	1.78	CHEMBL3125	Homo sapiens	Inhibition	%	1.78
	8139699	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	0.65	CHEMBL3125	Homo sapiens	Inhibition	%	0.65
	8140064	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	4.98	CHEMBL3125	Homo sapiens	Inhibition	%	4.98
	8140187	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	1.09	CHEMBL3125	Homo sapiens	Inhibition	%	1.09
	8140570	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.23	CHEMBL3125	Homo sapiens	Inhibition	%	1.23
	8140713	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	4.53	CHEMBL3125	Homo sapiens	Inhibition	%	4.53
	8140937	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	3.43	CHEMBL3125	Homo sapiens	Inhibition	%	3.43
	8141015	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.65	CHEMBL3125	Homo sapiens	Inhibition	%	0.65
	8141369	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.68	CHEMBL3125	Homo sapiens	Inhibition	%	1.68
	8141529	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	2.6	CHEMBL3125	Homo sapiens	Inhibition	%	2.6
	8141753	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	2.24	CHEMBL3125	Homo sapiens	Inhibition	%	2.24
	8141872	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	1.5	CHEMBL3125	Homo sapiens	Inhibition	%	1.5
	8142033	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	1.07	CHEMBL3125	Homo sapiens	Inhibition	%	1.07
	8142257	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-0.23	CHEMBL3125	Homo sapiens	Inhibition	%	-0.23
	8142425	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	0.0	CHEMBL3125	Homo sapiens	Inhibition	%	0.0
	8142601	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	2.66	CHEMBL3125	Homo sapiens	Inhibition	%	2.66
	8142825	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	1.78	CHEMBL3125	Homo sapiens	Inhibition	%	1.78
	8142974	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-2.17	CHEMBL3125	Homo sapiens	Inhibition	%	-2.17
	8143129	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.93	CHEMBL3125	Homo sapiens	Inhibition	%	1.93
	8143353	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.14	CHEMBL3125	Homo sapiens	Inhibition	%	3.14
	8143540	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	4.68	CHEMBL3125	Homo sapiens	Inhibition	%	4.68
	8143699	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	2.52	CHEMBL3125	Homo sapiens	Inhibition	%	2.52
	8143923	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	3.99	CHEMBL3125	Homo sapiens	Inhibition	%	3.99
	8144037	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	2.02	CHEMBL3125	Homo sapiens	Inhibition	%	2.02
	8144400	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	2.15	CHEMBL3125	Homo sapiens	Inhibition	%	2.15
	8144530	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	3.62	CHEMBL3125	Homo sapiens	Inhibition	%	3.62
	8144754	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	3.42	CHEMBL3125	Homo sapiens	Inhibition	%	3.42
	8144907	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.99	CHEMBL3125	Homo sapiens	Inhibition	%	1.99
	8145268	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	3.05	CHEMBL3125	Homo sapiens	Inhibition	%	3.05
	8145357	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.75	CHEMBL3125	Homo sapiens	Inhibition	%	1.75
	8145581	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	0.7	CHEMBL3125	Homo sapiens	Inhibition	%	0.7
	8145705	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	3.29	CHEMBL3125	Homo sapiens	Inhibition	%	3.29
	8146090	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	4.1	CHEMBL3125	Homo sapiens	Inhibition	%	4.1
	8146210	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.7	CHEMBL3125	Homo sapiens	Inhibition	%	0.7
	8146594	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	2.53	CHEMBL3125	Homo sapiens	Inhibition	%	2.53
	8146761	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	2.52	CHEMBL3125	Homo sapiens	Inhibition	%	2.52
	8147154	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	1.19	CHEMBL3125	Homo sapiens	Inhibition	%	1.19
	8147296	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.71	CHEMBL3125	Homo sapiens	Inhibition	%	1.71
	8147673	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.61	CHEMBL3125	Homo sapiens	Inhibition	%	2.61
	8147860	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	2.52	CHEMBL3125	Homo sapiens	Inhibition	%	2.52
	8148242	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	2.52	CHEMBL3125	Homo sapiens	Inhibition	%	2.52
	8148356	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	0.82	CHEMBL3125	Homo sapiens	Inhibition	%	0.82
	8148580	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	2.02	CHEMBL3125	Homo sapiens	Inhibition	%	2.02
	8148719	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	1.91	CHEMBL3125	Homo sapiens	Inhibition	%	1.91
	8149081	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	5.79	CHEMBL3125	Homo sapiens	Inhibition	%	5.79
	8149240	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	1.06	CHEMBL3125	Homo sapiens	Inhibition	%	1.06
	8149598	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	35.46	CHEMBL3125	Homo sapiens	Inhibition	%	35.46
	8149920	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	5.41	CHEMBL3125	Homo sapiens	Inhibition	%	5.41
	8150045	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	1.72	CHEMBL3125	Homo sapiens	Inhibition	%	1.72
	8150429	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.45	CHEMBL3125	Homo sapiens	Inhibition	%	0.45
	8150549	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.37	CHEMBL3125	Homo sapiens	Inhibition	%	0.37
	8150773	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.24	CHEMBL3125	Homo sapiens	Inhibition	%	0.24
	8150938	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-0.18	CHEMBL3125	Homo sapiens	Inhibition	%	-0.18
	8151101	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-1.94	CHEMBL3125	Homo sapiens	Inhibition	%	-1.94
	8151325	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-1.58	CHEMBL3125	Homo sapiens	Inhibition	%	-1.58
	8151502	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.26	CHEMBL3125	Homo sapiens	Inhibition	%	1.26
	8151640	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	0.86	CHEMBL3125	Homo sapiens	Inhibition	%	0.86
	8151864	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	1.4	CHEMBL3125	Homo sapiens	Inhibition	%	1.4
	8152018	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.73	CHEMBL3125	Homo sapiens	Inhibition	%	1.73
	8152206	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	6.18	CHEMBL3125	Homo sapiens	Inhibition	%	6.18
	8152430	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	2.15	CHEMBL3125	Homo sapiens	Inhibition	%	2.15
	8152588	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	3.34	CHEMBL3125	Homo sapiens	Inhibition	%	3.34
	8152926	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	0.35	CHEMBL3125	Homo sapiens	Inhibition	%	0.35
	8153065	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.66	CHEMBL3125	Homo sapiens	Inhibition	%	1.66
	8153426	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	3.28	CHEMBL3125	Homo sapiens	Inhibition	%	3.28
	8153583	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	1.76	CHEMBL3125	Homo sapiens	Inhibition	%	1.76
	8153807	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-0.81	CHEMBL3125	Homo sapiens	Inhibition	%	-0.81
	8153940	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	71.44	CHEMBL3125	Homo sapiens	Inhibition	%	71.44
	8154261	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	7.88	CHEMBL3125	Homo sapiens	Inhibition	%	7.88
	8154387	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	5.67	CHEMBL3125	Homo sapiens	Inhibition	%	5.67
	8154611	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	1.03	CHEMBL3125	Homo sapiens	Inhibition	%	1.03
	8154770	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.97	CHEMBL3125	Homo sapiens	Inhibition	%	1.97
	8155114	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	1.1	CHEMBL3125	Homo sapiens	Inhibition	%	1.1
	8155290	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	1.24	CHEMBL3125	Homo sapiens	Inhibition	%	1.24
	8155675	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	1.44	CHEMBL3125	Homo sapiens	Inhibition	%	1.44
	8155853	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	3.44	CHEMBL3125	Homo sapiens	Inhibition	%	3.44
	8156215	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	-0.01	CHEMBL3125	Homo sapiens	Inhibition	%	-0.01
	8156427	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	2.15	CHEMBL3125	Homo sapiens	Inhibition	%	2.15
	8156577	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	2.7	CHEMBL3125	Homo sapiens	Inhibition	%	2.7
	8156801	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.62	CHEMBL3125	Homo sapiens	Inhibition	%	2.62
	8156944	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	5.37	CHEMBL3125	Homo sapiens	Inhibition	%	5.37
	8157288	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	11.54	CHEMBL3125	Homo sapiens	Inhibition	%	11.54
	8157429	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	2.89	CHEMBL3125	Homo sapiens	Inhibition	%	2.89
	8157653	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	8.48	CHEMBL3125	Homo sapiens	Inhibition	%	8.48
	8157783	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	2.05	CHEMBL3125	Homo sapiens	Inhibition	%	2.05
	8158168	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	1.93	CHEMBL3125	Homo sapiens	Inhibition	%	1.93
	8158418	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	44.54	CHEMBL3125	Homo sapiens	Inhibition	%	44.54
	8158576	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	8.63	CHEMBL3125	Homo sapiens	Inhibition	%	8.63
	8158969	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	3.08	CHEMBL3125	Homo sapiens	Inhibition	%	3.08
	8159104	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	2.64	CHEMBL3125	Homo sapiens	Inhibition	%	2.64
	8159328	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	4.39	CHEMBL3125	Homo sapiens	Inhibition	%	4.39
	8159448	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	4.42	CHEMBL3125	Homo sapiens	Inhibition	%	4.42
	8159803	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	1.64	CHEMBL3125	Homo sapiens	Inhibition	%	1.64
	8159944	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	6.79	CHEMBL3125	Homo sapiens	Inhibition	%	6.79
	8160305	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	2.0	CHEMBL3125	Homo sapiens	Inhibition	%	2.0
	8160455	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-1.62	CHEMBL3125	Homo sapiens	Inhibition	%	-1.62
	8160749	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	4.27	CHEMBL3125	Homo sapiens	Inhibition	%	4.27
	8161123	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	3.19	CHEMBL3125	Homo sapiens	Inhibition	%	3.19
	8161266	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	2.97	CHEMBL3125	Homo sapiens	Inhibition	%	2.97
	8161490	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	6.51	CHEMBL3125	Homo sapiens	Inhibition	%	6.51
	8161615	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.39	CHEMBL3125	Homo sapiens	Inhibition	%	1.39
	8161977	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	3.37	CHEMBL3125	Homo sapiens	Inhibition	%	3.37
	8162107	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	3.19	CHEMBL3125	Homo sapiens	Inhibition	%	3.19
	8162491	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	2.99	CHEMBL3125	Homo sapiens	Inhibition	%	2.99
	8162744	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	74.32	CHEMBL3125	Homo sapiens	Inhibition	%	74.32
	8162892	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	28.81	CHEMBL3125	Homo sapiens	Inhibition	%	28.81
	8163116	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	63.9	CHEMBL3125	Homo sapiens	Inhibition	%	63.9
	8163285	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.95	CHEMBL3125	Homo sapiens	Inhibition	%	1.95
	8163643	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	3.5	CHEMBL3125	Homo sapiens	Inhibition	%	3.5
	8163766	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	8.86	CHEMBL3125	Homo sapiens	Inhibition	%	8.86
	8164124	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	7.01	CHEMBL3125	Homo sapiens	Inhibition	%	7.01
	8164264	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	2.08	CHEMBL3125	Homo sapiens	Inhibition	%	2.08
	8164488	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	3.62	CHEMBL3125	Homo sapiens	Inhibition	%	3.62
	8164643	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	2.1	CHEMBL3125	Homo sapiens	Inhibition	%	2.1
	8164787	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-0.73	CHEMBL3125	Homo sapiens	Inhibition	%	-0.73
	8165011	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	-1.0	CHEMBL3125	Homo sapiens	Inhibition	%	-1.0
	8165081	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	2.93	CHEMBL3125	Homo sapiens	Inhibition	%	2.93
	8165305	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	5.8	CHEMBL3125	Homo sapiens	Inhibition	%	5.8
	8165446	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	1.22	CHEMBL3125	Homo sapiens	Inhibition	%	1.22
	8165813	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	-0.06	CHEMBL3125	Homo sapiens	Inhibition	%	-0.06
	8165939	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	3.42	CHEMBL3125	Homo sapiens	Inhibition	%	3.42
	8166301	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	5.59	CHEMBL3125	Homo sapiens	Inhibition	%	5.59
	8166431	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	1.9	CHEMBL3125	Homo sapiens	Inhibition	%	1.9
	8166655	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	3.89	CHEMBL3125	Homo sapiens	Inhibition	%	3.89
	8166756	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	2.58	CHEMBL3125	Homo sapiens	Inhibition	%	2.58
	8167068	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	56.74	CHEMBL3125	Homo sapiens	Inhibition	%	56.74
	8167433	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	5.18	CHEMBL3125	Homo sapiens	Inhibition	%	5.18
	8167597	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.56	CHEMBL3125	Homo sapiens	Inhibition	%	2.56
	8167954	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	10.77	CHEMBL3125	Homo sapiens	Inhibition	%	10.77
	8168078	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	3.34	CHEMBL3125	Homo sapiens	Inhibition	%	3.34
	8168302	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	16.68	CHEMBL3125	Homo sapiens	Inhibition	%	16.68
	8168443	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	1.44	CHEMBL3125	Homo sapiens	Inhibition	%	1.44
	8168803	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-0.84	CHEMBL3125	Homo sapiens	Inhibition	%	-0.84
	8168967	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	8.46	CHEMBL3125	Homo sapiens	Inhibition	%	8.46
	8169333	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	3.37	CHEMBL3125	Homo sapiens	Inhibition	%	3.37
	8169637	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	4.34	CHEMBL3125	Homo sapiens	Inhibition	%	4.34
	8169771	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	2.51	CHEMBL3125	Homo sapiens	Inhibition	%	2.51
	8170140	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	20.06	CHEMBL3125	Homo sapiens	Inhibition	%	20.06
	8170265	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.89	CHEMBL3125	Homo sapiens	Inhibition	%	1.89
	8170489	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.82	CHEMBL3125	Homo sapiens	Inhibition	%	3.82
	8170629	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	4.39	CHEMBL3125	Homo sapiens	Inhibition	%	4.39
	8170988	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	1.31	CHEMBL3125	Homo sapiens	Inhibition	%	1.31
	8171185	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	1.54	CHEMBL3125	Homo sapiens	Inhibition	%	1.54
	8171402	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	76.72	CHEMBL3125	Homo sapiens	Inhibition	%	76.72
	8171767	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	13.85	CHEMBL3125	Homo sapiens	Inhibition	%	13.85
	8171920	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	2.4	CHEMBL3125	Homo sapiens	Inhibition	%	2.4
	8172144	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	2.89	CHEMBL3125	Homo sapiens	Inhibition	%	2.89
	8172276	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	3.86	CHEMBL3125	Homo sapiens	Inhibition	%	3.86
	8172628	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.76	CHEMBL3125	Homo sapiens	Inhibition	%	0.76
	8172770	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	2.05	CHEMBL3125	Homo sapiens	Inhibition	%	2.05
	8173130	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	0.37	CHEMBL3125	Homo sapiens	Inhibition	%	0.37
	8173295	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	2.47	CHEMBL3125	Homo sapiens	Inhibition	%	2.47
	8173519	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	4.26	CHEMBL3125	Homo sapiens	Inhibition	%	4.26
	8173660	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	0.89	CHEMBL3125	Homo sapiens	Inhibition	%	0.89
	8173971	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	18.72	CHEMBL3125	Homo sapiens	Inhibition	%	18.72
	8174103	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.57	CHEMBL3125	Homo sapiens	Inhibition	%	2.57
	8174327	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	3.67	CHEMBL3125	Homo sapiens	Inhibition	%	3.67
	8174475	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	0.7	CHEMBL3125	Homo sapiens	Inhibition	%	0.7
	8174821	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.61	CHEMBL3125	Homo sapiens	Inhibition	%	1.61
	8174964	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	19.24	CHEMBL3125	Homo sapiens	Inhibition	%	19.24
	8175324	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	2.98	CHEMBL3125	Homo sapiens	Inhibition	%	2.98
	8175580	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	13.41	CHEMBL3125	Homo sapiens	Inhibition	%	13.41
	8175743	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	4.88	CHEMBL3125	Homo sapiens	Inhibition	%	4.88
	8175967	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	6.94	CHEMBL3125	Homo sapiens	Inhibition	%	6.94
	8176120	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	20.09	CHEMBL3125	Homo sapiens	Inhibition	%	20.09
	8176493	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	1.96	CHEMBL3125	Homo sapiens	Inhibition	%	1.96
	8176625	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	16.57	CHEMBL3125	Homo sapiens	Inhibition	%	16.57
	8176979	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	3.98	CHEMBL3125	Homo sapiens	Inhibition	%	3.98
	8177121	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	1.46	CHEMBL3125	Homo sapiens	Inhibition	%	1.46
	8177345	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	2.78	CHEMBL3125	Homo sapiens	Inhibition	%	2.78
	8177483	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	11.77	CHEMBL3125	Homo sapiens	Inhibition	%	11.77
	8177871	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	3.18	CHEMBL3125	Homo sapiens	Inhibition	%	3.18
	8178011	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	2.67	CHEMBL3125	Homo sapiens	Inhibition	%	2.67
	8178323	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	0.06	CHEMBL3125	Homo sapiens	Inhibition	%	0.06
	8178674	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	2.78	CHEMBL3125	Homo sapiens	Inhibition	%	2.78
	8178823	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	3.88	CHEMBL3125	Homo sapiens	Inhibition	%	3.88
	8179170	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.66	CHEMBL3125	Homo sapiens	Inhibition	%	2.66
	8179314	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	3.9	CHEMBL3125	Homo sapiens	Inhibition	%	3.9
	8179538	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	14.53	CHEMBL3125	Homo sapiens	Inhibition	%	14.53
	8179675	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.76	CHEMBL3125	Homo sapiens	Inhibition	%	1.76
	8179932	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	2.89	CHEMBL3125	Homo sapiens	Inhibition	%	2.89
	8180310	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	3.11	CHEMBL3125	Homo sapiens	Inhibition	%	3.11
	8180466	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	63.29	CHEMBL3125	Homo sapiens	Inhibition	%	63.29
	8180838	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	3.55	CHEMBL3125	Homo sapiens	Inhibition	%	3.55
	8180971	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	2.55	CHEMBL3125	Homo sapiens	Inhibition	%	2.55
	8181195	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	3.94	CHEMBL3125	Homo sapiens	Inhibition	%	3.94
	8181326	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	1.38	CHEMBL3125	Homo sapiens	Inhibition	%	1.38
	8181690	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	2.14	CHEMBL3125	Homo sapiens	Inhibition	%	2.14
	8181829	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	45.26	CHEMBL3125	Homo sapiens	Inhibition	%	45.26
	8182053	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	3.37	CHEMBL3125	Homo sapiens	Inhibition	%	3.37
	8182216	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	4.49	CHEMBL3125	Homo sapiens	Inhibition	%	4.49
	8182356	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	-0.61	CHEMBL3125	Homo sapiens	Inhibition	%	-0.61
	8182580	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	2.0	CHEMBL3125	Homo sapiens	Inhibition	%	2.0
	8182672	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	4.03	CHEMBL3125	Homo sapiens	Inhibition	%	4.03
	8183018	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	4.13	CHEMBL3125	Homo sapiens	Inhibition	%	4.13
	8183167	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	-0.21	CHEMBL3125	Homo sapiens	Inhibition	%	-0.21
	8183391	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	3.76	CHEMBL3125	Homo sapiens	Inhibition	%	3.76
	8183520	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	5.05	CHEMBL3125	Homo sapiens	Inhibition	%	5.05
	8183886	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	2.66	CHEMBL3125	Homo sapiens	Inhibition	%	2.66
	8184022	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.8	CHEMBL3125	Homo sapiens	Inhibition	%	1.8
	8184246	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	1.78	CHEMBL3125	Homo sapiens	Inhibition	%	1.78
	8184288	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	4.31	CHEMBL3125	Homo sapiens	Inhibition	%	4.31
	8184512	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.85	CHEMBL3125	Homo sapiens	Inhibition	%	2.85
	8184659	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	4.08	CHEMBL3125	Homo sapiens	Inhibition	%	4.08
	8184816	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	0.67	CHEMBL3125	Homo sapiens	Inhibition	%	0.67
	8185040	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	3.9	CHEMBL3125	Homo sapiens	Inhibition	%	3.9
	8185189	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.45	CHEMBL3125	Homo sapiens	Inhibition	%	0.45
	8185544	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	3.12	CHEMBL3125	Homo sapiens	Inhibition	%	3.12
	8185675	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	17.66	CHEMBL3125	Homo sapiens	Inhibition	%	17.66
	8185899	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	1.76	CHEMBL3125	Homo sapiens	Inhibition	%	1.76
	8186038	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	1.76	CHEMBL3125	Homo sapiens	Inhibition	%	1.76
	8186403	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	4.5	CHEMBL3125	Homo sapiens	Inhibition	%	4.5
	8186567	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	2.26	CHEMBL3125	Homo sapiens	Inhibition	%	2.26
	8186930	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	3.22	CHEMBL3125	Homo sapiens	Inhibition	%	3.22
	8187028	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.67	CHEMBL3125	Homo sapiens	Inhibition	%	1.67
	8187252	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	2.18	CHEMBL3125	Homo sapiens	Inhibition	%	2.18
	8187376	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	2.99	CHEMBL3125	Homo sapiens	Inhibition	%	2.99
	8187748	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	0.51	CHEMBL3125	Homo sapiens	Inhibition	%	0.51
	8187877	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	6.41	CHEMBL3125	Homo sapiens	Inhibition	%	6.41
	8188101	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	3.89	CHEMBL3125	Homo sapiens	Inhibition	%	3.89
	8188244	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	5.77	CHEMBL3125	Homo sapiens	Inhibition	%	5.77
	8188603	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	2.04	CHEMBL3125	Homo sapiens	Inhibition	%	2.04
	8188877	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.7	CHEMBL3125	Homo sapiens	Inhibition	%	4.7
	8189025	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	2.2	CHEMBL3125	Homo sapiens	Inhibition	%	2.2
	8189405	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	2.95	CHEMBL3125	Homo sapiens	Inhibition	%	2.95
	8189554	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	4.0	CHEMBL3125	Homo sapiens	Inhibition	%	4.0
	8189910	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	3.4	CHEMBL3125	Homo sapiens	Inhibition	%	3.4
	8190266	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	6.3	CHEMBL3125	Homo sapiens	Inhibition	%	6.3
	8190406	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	2.32	CHEMBL3125	Homo sapiens	Inhibition	%	2.32
	8190767	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	1.86	CHEMBL3125	Homo sapiens	Inhibition	%	1.86
	8190931	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	3.24	CHEMBL3125	Homo sapiens	Inhibition	%	3.24
	8191293	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	4.32	CHEMBL3125	Homo sapiens	Inhibition	%	4.32
	8191613	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.12	CHEMBL3125	Homo sapiens	Inhibition	%	2.12
	8191735	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	7.19	CHEMBL3125	Homo sapiens	Inhibition	%	7.19
	8191959	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	0.49	CHEMBL3125	Homo sapiens	Inhibition	%	0.49
	8192108	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.52	CHEMBL3125	Homo sapiens	Inhibition	%	2.52
	8192461	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	4.66	CHEMBL3125	Homo sapiens	Inhibition	%	4.66
	8192605	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	2.58	CHEMBL3125	Homo sapiens	Inhibition	%	2.58
	8192965	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	1.07	CHEMBL3125	Homo sapiens	Inhibition	%	1.07
	8193237	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	2.03	CHEMBL3125	Homo sapiens	Inhibition	%	2.03
	8193382	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.83	CHEMBL3125	Homo sapiens	Inhibition	%	1.83
	8193606	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	0.79	CHEMBL3125	Homo sapiens	Inhibition	%	0.79
	8193763	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	18.55	CHEMBL3125	Homo sapiens	Inhibition	%	18.55
	8193912	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.68	CHEMBL3125	Homo sapiens	Inhibition	%	-0.68
	8194136	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	3.67	CHEMBL3125	Homo sapiens	Inhibition	%	3.67
	8194267	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	4.36	CHEMBL3125	Homo sapiens	Inhibition	%	4.36
	8194622	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	1.73	CHEMBL3125	Homo sapiens	Inhibition	%	1.73
	8194765	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	3.43	CHEMBL3125	Homo sapiens	Inhibition	%	3.43
	8194989	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	1.93	CHEMBL3125	Homo sapiens	Inhibition	%	1.93
	8195122	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	4.02	CHEMBL3125	Homo sapiens	Inhibition	%	4.02
	8195286	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	0.41	CHEMBL3125	Homo sapiens	Inhibition	%	0.41
	8195510	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	4.81	CHEMBL3125	Homo sapiens	Inhibition	%	4.81
	8195649	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	1.01	CHEMBL3125	Homo sapiens	Inhibition	%	1.01
	8195971	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	14.86	CHEMBL3125	Homo sapiens	Inhibition	%	14.86
	8196312	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.83	CHEMBL3125	Homo sapiens	Inhibition	%	2.83
	8196462	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	0.97	CHEMBL3125	Homo sapiens	Inhibition	%	0.97
	8196814	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	4.25	CHEMBL3125	Homo sapiens	Inhibition	%	4.25
	8196955	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	4.27	CHEMBL3125	Homo sapiens	Inhibition	%	4.27
	8197179	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	1.86	CHEMBL3125	Homo sapiens	Inhibition	%	1.86
	8197316	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-0.61	CHEMBL3125	Homo sapiens	Inhibition	%	-0.61
	8197591	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	2.52	CHEMBL3125	Homo sapiens	Inhibition	%	2.52
	8197955	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	3.02	CHEMBL3125	Homo sapiens	Inhibition	%	3.02
	8198112	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	1.65	CHEMBL3125	Homo sapiens	Inhibition	%	1.65
	8198474	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	2.17	CHEMBL3125	Homo sapiens	Inhibition	%	2.17
	8198604	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	2.32	CHEMBL3125	Homo sapiens	Inhibition	%	2.32
	8198828	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	3.55	CHEMBL3125	Homo sapiens	Inhibition	%	3.55
	8198959	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	4.02	CHEMBL3125	Homo sapiens	Inhibition	%	4.02
	8199331	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	2.96	CHEMBL3125	Homo sapiens	Inhibition	%	2.96
	8199465	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	2.46	CHEMBL3125	Homo sapiens	Inhibition	%	2.46
	8199852	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.86	CHEMBL3125	Homo sapiens	Inhibition	%	1.86
	8199990	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	3.89	CHEMBL3125	Homo sapiens	Inhibition	%	3.89
	8200214	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	0.94	CHEMBL3125	Homo sapiens	Inhibition	%	0.94
	8200318	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.0	CHEMBL3125	Homo sapiens	Inhibition	%	1.0
	8200657	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	2.93	CHEMBL3125	Homo sapiens	Inhibition	%	2.93
	8200807	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	3.78	CHEMBL3125	Homo sapiens	Inhibition	%	3.78
	8201031	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	0.89	CHEMBL3125	Homo sapiens	Inhibition	%	0.89
	8201161	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	8.0	CHEMBL3125	Homo sapiens	Inhibition	%	8.0
	8201520	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.64	CHEMBL3125	Homo sapiens	Inhibition	%	2.64
	8201653	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.04	CHEMBL3125	Homo sapiens	Inhibition	%	-0.04
	8201932	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.67	CHEMBL3125	Homo sapiens	Inhibition	%	2.67
	8202296	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.47	CHEMBL3125	Homo sapiens	Inhibition	%	-1.47
	8202463	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	5.1	CHEMBL3125	Homo sapiens	Inhibition	%	5.1
	8202687	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.18	CHEMBL3125	Homo sapiens	Inhibition	%	3.18
	8202812	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	3.21	CHEMBL3125	Homo sapiens	Inhibition	%	3.21
	8203166	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	3.97	CHEMBL3125	Homo sapiens	Inhibition	%	3.97
	8203297	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	2.14	CHEMBL3125	Homo sapiens	Inhibition	%	2.14
	8203667	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	5.88	CHEMBL3125	Homo sapiens	Inhibition	%	5.88
	8203801	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.37	CHEMBL3125	Homo sapiens	Inhibition	%	4.37
	8204025	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	3.45	CHEMBL3125	Homo sapiens	Inhibition	%	3.45
	8204191	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	3.1	CHEMBL3125	Homo sapiens	Inhibition	%	3.1
	8204552	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	2.96	CHEMBL3125	Homo sapiens	Inhibition	%	2.96
	8204657	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	2.91	CHEMBL3125	Homo sapiens	Inhibition	%	2.91
	8204881	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	0.74	CHEMBL3125	Homo sapiens	Inhibition	%	0.74
	8204996	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	8.42	CHEMBL3125	Homo sapiens	Inhibition	%	8.42
	8205369	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	6.24	CHEMBL3125	Homo sapiens	Inhibition	%	6.24
	8205505	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	6.75	CHEMBL3125	Homo sapiens	Inhibition	%	6.75
	8205868	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.17	CHEMBL3125	Homo sapiens	Inhibition	%	2.17
	8206000	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.04	CHEMBL3125	Homo sapiens	Inhibition	%	-0.04
	8206224	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-2.08	CHEMBL3125	Homo sapiens	Inhibition	%	-2.08
	8206276	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.44	CHEMBL3125	Homo sapiens	Inhibition	%	2.44
	8206500	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	3.07	CHEMBL3125	Homo sapiens	Inhibition	%	3.07
	8206643	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-0.48	CHEMBL3125	Homo sapiens	Inhibition	%	-0.48
	8207047	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	13.87	CHEMBL3125	Homo sapiens	Inhibition	%	13.87
	8207173	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	2.91	CHEMBL3125	Homo sapiens	Inhibition	%	2.91
	8207527	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	2.78	CHEMBL3125	Homo sapiens	Inhibition	%	2.78
	8207659	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	5.76	CHEMBL3125	Homo sapiens	Inhibition	%	5.76
	8207883	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	2.88	CHEMBL3125	Homo sapiens	Inhibition	%	2.88
	8208028	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	7.41	CHEMBL3125	Homo sapiens	Inhibition	%	7.41
	8208384	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	4.77	CHEMBL3125	Homo sapiens	Inhibition	%	4.77
	8208550	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	6.16	CHEMBL3125	Homo sapiens	Inhibition	%	6.16
	8208907	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	44.58	CHEMBL3125	Homo sapiens	Inhibition	%	44.58
	8209236	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	1.94	CHEMBL3125	Homo sapiens	Inhibition	%	1.94
	8209352	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.3	CHEMBL3125	Homo sapiens	Inhibition	%	1.3
	8209576	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	3.24	CHEMBL3125	Homo sapiens	Inhibition	%	3.24
	8209726	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	-0.31	CHEMBL3125	Homo sapiens	Inhibition	%	-0.31
	8209862	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	27.64	CHEMBL3125	Homo sapiens	Inhibition	%	27.64
	8210086	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	4.32	CHEMBL3125	Homo sapiens	Inhibition	%	4.32
	8210227	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.4	CHEMBL3125	Homo sapiens	Inhibition	%	2.4
	8210587	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-1.67	CHEMBL3125	Homo sapiens	Inhibition	%	-1.67
	8210846	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	3.61	CHEMBL3125	Homo sapiens	Inhibition	%	3.61
	8210990	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	0.54	CHEMBL3125	Homo sapiens	Inhibition	%	0.54
	8211384	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	2.95	CHEMBL3125	Homo sapiens	Inhibition	%	2.95
	8211507	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	3.45	CHEMBL3125	Homo sapiens	Inhibition	%	3.45
	8211731	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	3.14	CHEMBL3125	Homo sapiens	Inhibition	%	3.14
	8211860	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	6.3	CHEMBL3125	Homo sapiens	Inhibition	%	6.3
	8212216	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	6.76	CHEMBL3125	Homo sapiens	Inhibition	%	6.76
	8212357	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	6.38	CHEMBL3125	Homo sapiens	Inhibition	%	6.38
	8212581	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	8.25	CHEMBL3125	Homo sapiens	Inhibition	%	8.25
	8212714	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	3.13	CHEMBL3125	Homo sapiens	Inhibition	%	3.13
	8212884	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	34.07	CHEMBL3125	Homo sapiens	Inhibition	%	34.07
	8213108	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.31	CHEMBL3125	Homo sapiens	Inhibition	%	1.31
	8213237	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	75.13	CHEMBL3125	Homo sapiens	Inhibition	%	75.13
	8213565	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-2.17	CHEMBL3125	Homo sapiens	Inhibition	%	-2.17
	8213902	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.36	CHEMBL3125	Homo sapiens	Inhibition	%	2.36
	8214049	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	4.18	CHEMBL3125	Homo sapiens	Inhibition	%	4.18
	8214410	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	13.77	CHEMBL3125	Homo sapiens	Inhibition	%	13.77
	8214544	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	2.41	CHEMBL3125	Homo sapiens	Inhibition	%	2.41
	8214768	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	4.49	CHEMBL3125	Homo sapiens	Inhibition	%	4.49
	8214920	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	3.23	CHEMBL3125	Homo sapiens	Inhibition	%	3.23
	8215171	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	4.22	CHEMBL3125	Homo sapiens	Inhibition	%	4.22
	8215324	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	3.06	CHEMBL3125	Homo sapiens	Inhibition	%	3.06
	8215548	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	1.64	CHEMBL3125	Homo sapiens	Inhibition	%	1.64
	8215712	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	4.34	CHEMBL3125	Homo sapiens	Inhibition	%	4.34
	8216055	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	4.18	CHEMBL3125	Homo sapiens	Inhibition	%	4.18
	8216174	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	3.18	CHEMBL3125	Homo sapiens	Inhibition	%	3.18
	8216398	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	5.34	CHEMBL3125	Homo sapiens	Inhibition	%	5.34
	8216534	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	16.34	CHEMBL3125	Homo sapiens	Inhibition	%	16.34
	8216896	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	48.88	CHEMBL3125	Homo sapiens	Inhibition	%	48.88
	8217030	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	3.75	CHEMBL3125	Homo sapiens	Inhibition	%	3.75
	8217428	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	3.78	CHEMBL3125	Homo sapiens	Inhibition	%	3.78
	8217559	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	3.93	CHEMBL3125	Homo sapiens	Inhibition	%	3.93
	8217884	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.54	CHEMBL3125	Homo sapiens	Inhibition	%	-1.54
	8218223	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	4.48	CHEMBL3125	Homo sapiens	Inhibition	%	4.48
	8218350	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	1.32	CHEMBL3125	Homo sapiens	Inhibition	%	1.32
	8218574	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	4.69	CHEMBL3125	Homo sapiens	Inhibition	%	4.69
	8218717	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	4.9	CHEMBL3125	Homo sapiens	Inhibition	%	4.9
	8219072	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	2.16	CHEMBL3125	Homo sapiens	Inhibition	%	2.16
	8219232	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	3.34	CHEMBL3125	Homo sapiens	Inhibition	%	3.34
	8219482	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	3.46	CHEMBL3125	Homo sapiens	Inhibition	%	3.46
	8219867	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	3.84	CHEMBL3125	Homo sapiens	Inhibition	%	3.84
	8220036	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	1.67	CHEMBL3125	Homo sapiens	Inhibition	%	1.67
	8220389	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	3.12	CHEMBL3125	Homo sapiens	Inhibition	%	3.12
	8220727	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	32.37	CHEMBL3125	Homo sapiens	Inhibition	%	32.37
	8220865	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	56.72	CHEMBL3125	Homo sapiens	Inhibition	%	56.72
	8221225	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	74.53	CHEMBL3125	Homo sapiens	Inhibition	%	74.53
	8221358	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	0.48	CHEMBL3125	Homo sapiens	Inhibition	%	0.48
	8221582	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	2.67	CHEMBL3125	Homo sapiens	Inhibition	%	2.67
	8221747	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.59	CHEMBL3125	Homo sapiens	Inhibition	%	0.59
	8221878	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	10.01	CHEMBL3125	Homo sapiens	Inhibition	%	10.01
	8222102	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	1.39	CHEMBL3125	Homo sapiens	Inhibition	%	1.39
	8222200	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	0.6	CHEMBL3125	Homo sapiens	Inhibition	%	0.6
	8222558	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	3.0	CHEMBL3125	Homo sapiens	Inhibition	%	3.0
	8222900	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	1.31	CHEMBL3125	Homo sapiens	Inhibition	%	1.31
	8223044	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	24.16	CHEMBL3125	Homo sapiens	Inhibition	%	24.16
	8223397	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	3.01	CHEMBL3125	Homo sapiens	Inhibition	%	3.01
	8223558	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	1.99	CHEMBL3125	Homo sapiens	Inhibition	%	1.99
	8223782	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	1.84	CHEMBL3125	Homo sapiens	Inhibition	%	1.84
	8223808	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	7.21	CHEMBL3125	Homo sapiens	Inhibition	%	7.21
	8224032	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	9.9	CHEMBL3125	Homo sapiens	Inhibition	%	9.9
	8224194	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	3.43	CHEMBL3125	Homo sapiens	Inhibition	%	3.43
	8224364	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	3.45	CHEMBL3125	Homo sapiens	Inhibition	%	3.45
	8224588	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	1.8	CHEMBL3125	Homo sapiens	Inhibition	%	1.8
	8224723	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	2.3	CHEMBL3125	Homo sapiens	Inhibition	%	2.3
	8225061	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	68.94	CHEMBL3125	Homo sapiens	Inhibition	%	68.94
	8225195	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	2.94	CHEMBL3125	Homo sapiens	Inhibition	%	2.94
	8225419	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	9.16	CHEMBL3125	Homo sapiens	Inhibition	%	9.16
	8225557	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	5.25	CHEMBL3125	Homo sapiens	Inhibition	%	5.25
	8225916	CHEMBL1961890	GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	2.5	CHEMBL3125	Homo sapiens	Inhibition	%	2.5
	8226074	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.2	CHEMBL3125	Homo sapiens	Inhibition	%	2.2
	8226423	CHEMBL1961891	GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	4.41	CHEMBL3125	Homo sapiens	Inhibition	%	4.41
inactive	9620404	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	1584.89	CHEMBL3125	Homo sapiens	pKi		5.8
active	9620405	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Ki	nM	50.12	CHEMBL3125	Homo sapiens	pKi		7.3
inactive	9620406	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	1584.89	CHEMBL3125	Homo sapiens	pKi		5.8
active	9620407	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	=	Ki	nM	39.81	CHEMBL3125	Homo sapiens	pKi		7.4
active	9620408	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	=	Ki	nM	630.96	CHEMBL3125	Homo sapiens	pKi		6.2
inactive	9620409	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	<	Ki	nM	1584.89	CHEMBL3125	Homo sapiens	pKi		5.8
inactive	9620410	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	1584.89	CHEMBL3125	Homo sapiens	pKi		5.8
inactive	9620411	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	<	Ki	nM	1584.89	CHEMBL3125	Homo sapiens	pKi		5.8
active	9620412	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	=	Ki	nM	63.1	CHEMBL3125	Homo sapiens	pKi		7.2
active	9620413	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	=	Ki	nM	19.95	CHEMBL3125	Homo sapiens	pKi		7.7
inactive	9620414	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	1584.89	CHEMBL3125	Homo sapiens	pKi		5.8
active	9620415	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	=	Ki	nM	1584.89	CHEMBL3125	Homo sapiens	pKi		5.8
inactive	9620416	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	1584.89	CHEMBL3125	Homo sapiens	pKi		5.8
active	9620417	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	=	Ki	nM	794.33	CHEMBL3125	Homo sapiens	pKi		6.1
inactive	9620418	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	1584.89	CHEMBL3125	Homo sapiens	pKi		5.8
active	9620419	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	=	Ki	nM	158.49	CHEMBL3125	Homo sapiens	pKi		6.8
inactive	9620420	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	1584.89	CHEMBL3125	Homo sapiens	pKi		5.8
active	9620421	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	=	Ki	nM	100.0	CHEMBL3125	Homo sapiens	pKi		7.0
active	9620422	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	=	Ki	nM	158.49	CHEMBL3125	Homo sapiens	pKi		6.8
inactive	9620423	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	1584.89	CHEMBL3125	Homo sapiens	pKi		5.8
active	9620424	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	=	Ki	nM	100.0	CHEMBL3125	Homo sapiens	pKi		7.0
active	9620425	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	=	Ki	nM	199.53	CHEMBL3125	Homo sapiens	pKi		6.7
active	9620426	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	=	Ki	nM	199.53	CHEMBL3125	Homo sapiens	pKi		6.7
inactive	9620427	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	1584.89	CHEMBL3125	Homo sapiens	pKi		5.8
inactive	9620428	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	1584.89	CHEMBL3125	Homo sapiens	pKi		5.8
inactive	9620429	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	<	Ki	nM	1584.89	CHEMBL3125	Homo sapiens	pKi		5.8
active	9620430	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	=	Ki	nM	125.89	CHEMBL3125	Homo sapiens	pKi		6.9
active	9620431	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	Cc1ccc(-n2nc(C)c3c(=O)c4cc(Cl)ccc4n(O)c32)cc1		CHEMBL1991143	=	Ki	nM	1258.93	CHEMBL3125	Homo sapiens	pKi		5.9
active	9620432	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	=	Ki	nM	79.43	CHEMBL3125	Homo sapiens	pKi		7.1
inactive	9620433	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	1584.89	CHEMBL3125	Homo sapiens	pKi		5.8
active	9620434	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	=	Ki	nM	251.19	CHEMBL3125	Homo sapiens	pKi		6.6
active	9620435	CHEMBL1963732	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA4	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	=	Ki	nM	251.19	CHEMBL3125	Homo sapiens	pKi		6.6
	10839412	CHEMBL2015074	Inhibition of MSK2 N-terminal at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	16.0	CHEMBL3125	Homo sapiens	INH	%	16.0
	10926114	CHEMBL2046206	Inhibition of human MSK2 assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	CC(C)Nc1cc(-c2oc3ccccc3c(=O)c2-c2ccc(F)cc2)ccn1		CHEMBL2041958	=	Activity	%	89.0	CHEMBL3125	Homo sapiens	Activity	%	89.0
	10926115	CHEMBL2046206	Inhibition of human MSK2 assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)oc2ccccc12		CHEMBL2041962	=	Activity	%	95.0	CHEMBL3125	Homo sapiens	Activity	%	95.0
	10984759	CHEMBL2072055	Inhibition of human Rsk4 at 1 uM	B	Nc1cc(Nc2cnccn2)nc(-c2ccnc(N3CCNCC3)c2)c1		CHEMBL2069349	<	Inhibition	%	50.0	CHEMBL3125	Homo sapiens	INH	%	50.0
	12047271	CHEMBL2157296	Inhibition of MSK2 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	4.3	CHEMBL3125	Homo sapiens	INH	%	4.3
	12145285	CHEMBL2186667	Inhibition of RSK4 using fluorescent labelled substrate at 5 uM by caliper method	B	Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1		CHEMBL2177819	>	Inhibition	%	25.0	CHEMBL3125	Homo sapiens	INH	%	25.0
	12145286	CHEMBL2186667	Inhibition of RSK4 using fluorescent labelled substrate at 5 uM by caliper method	B	Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CC(=O)Nc2ccccc2)cc1		CHEMBL2177818	>	Inhibition	%	25.0	CHEMBL3125	Homo sapiens	INH	%	25.0
	12145313	CHEMBL2187086	Inhibition of MSK2 using fluorescent labelled substrate at 5 uM by caliper method	B	Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1		CHEMBL2177819	>	Inhibition	%	25.0	CHEMBL3125	Homo sapiens	INH	%	25.0
	12145314	CHEMBL2187086	Inhibition of MSK2 using fluorescent labelled substrate at 5 uM by caliper method	B	Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CC(=O)Nc2ccccc2)cc1		CHEMBL2177818	>	Inhibition	%	25.0	CHEMBL3125	Homo sapiens	INH	%	25.0
	12151774	CHEMBL2188020	Inhibition of MSK2 at 1 uM	B	CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)CC3)CC1)c1ccc(Cl)cc1		CHEMBL2177385	>	Inhibition	%	90.0	CHEMBL3125	Homo sapiens	INH	%	90.0
	12172222	CHEMBL2212002	Inhibition of RPS6KA4 C-terminal domain 2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL3125	Homo sapiens	Activity	%	100.0
	12172223	CHEMBL2212004	Inhibition of RPS6KA4 N-terminal domain 1 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	97.0	CHEMBL3125	Homo sapiens	Activity	%	97.0
	12183816	CHEMBL2214445	Inhibition of RPS6KA4	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL3125	Homo sapiens	pIC50		5.0
	12246286	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	97.0	CHEMBL3125	Homo sapiens	Residual Activity	%	97.0
	12246287	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	49.0	CHEMBL3125	Homo sapiens	Residual Activity	%	49.0
	12246288	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	96.0	CHEMBL3125	Homo sapiens	Residual Activity	%	96.0
	12246289	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	105.0	CHEMBL3125	Homo sapiens	Residual Activity	%	105.0
	12246290	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	104.0	CHEMBL3125	Homo sapiens	Residual Activity	%	104.0
	12246291	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	113.0	CHEMBL3125	Homo sapiens	Residual Activity	%	113.0
	12246292	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	56.0	CHEMBL3125	Homo sapiens	Residual Activity	%	56.0
	12246293	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	93.0	CHEMBL3125	Homo sapiens	Residual Activity	%	93.0
	12246294	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	101.0	CHEMBL3125	Homo sapiens	Residual Activity	%	101.0
	12246295	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	102.0	CHEMBL3125	Homo sapiens	Residual Activity	%	102.0
	12246296	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	97.0	CHEMBL3125	Homo sapiens	Residual Activity	%	97.0
	12246297	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	95.0	CHEMBL3125	Homo sapiens	Residual Activity	%	95.0
	12246298	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	94.0	CHEMBL3125	Homo sapiens	Residual Activity	%	94.0
	12246299	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	95.0	CHEMBL3125	Homo sapiens	Residual Activity	%	95.0
	12246300	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	81.0	CHEMBL3125	Homo sapiens	Residual Activity	%	81.0
	12246301	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	87.0	CHEMBL3125	Homo sapiens	Residual Activity	%	87.0
	12246302	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	108.0	CHEMBL3125	Homo sapiens	Residual Activity	%	108.0
	12246303	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	105.0	CHEMBL3125	Homo sapiens	Residual Activity	%	105.0
	12246304	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	91.0	CHEMBL3125	Homo sapiens	Residual Activity	%	91.0
	12246305	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	36.0	CHEMBL3125	Homo sapiens	Residual Activity	%	36.0
	12246306	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	94.0	CHEMBL3125	Homo sapiens	Residual Activity	%	94.0
	12246307	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	97.0	CHEMBL3125	Homo sapiens	Residual Activity	%	97.0
	12246308	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	90.0	CHEMBL3125	Homo sapiens	Residual Activity	%	90.0
	12246309	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	87.0	CHEMBL3125	Homo sapiens	Residual Activity	%	87.0
	12246310	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	108.0	CHEMBL3125	Homo sapiens	Residual Activity	%	108.0
	12246311	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	105.0	CHEMBL3125	Homo sapiens	Residual Activity	%	105.0
	12246312	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	67.0	CHEMBL3125	Homo sapiens	Residual Activity	%	67.0
	12246313	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	83.0	CHEMBL3125	Homo sapiens	Residual Activity	%	83.0
	12246314	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	93.0	CHEMBL3125	Homo sapiens	Residual Activity	%	93.0
	12246315	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	22.0	CHEMBL3125	Homo sapiens	Residual Activity	%	22.0
	12246316	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	89.0	CHEMBL3125	Homo sapiens	Residual Activity	%	89.0
	12246317	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	92.0	CHEMBL3125	Homo sapiens	Residual Activity	%	92.0
	12246318	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	106.0	CHEMBL3125	Homo sapiens	Residual Activity	%	106.0
	12246319	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	106.0	CHEMBL3125	Homo sapiens	Residual Activity	%	106.0
	12246320	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	91.0	CHEMBL3125	Homo sapiens	Residual Activity	%	91.0
	12246321	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	95.0	CHEMBL3125	Homo sapiens	Residual Activity	%	95.0
	12246322	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	96.0	CHEMBL3125	Homo sapiens	Residual Activity	%	96.0
	12246323	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	87.0	CHEMBL3125	Homo sapiens	Residual Activity	%	87.0
	12246324	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	97.0	CHEMBL3125	Homo sapiens	Residual Activity	%	97.0
	12246325	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	88.0	CHEMBL3125	Homo sapiens	Residual Activity	%	88.0
	12246326	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	111.0	CHEMBL3125	Homo sapiens	Residual Activity	%	111.0
	12246327	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	92.0	CHEMBL3125	Homo sapiens	Residual Activity	%	92.0
	12246328	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	2.0	CHEMBL3125	Homo sapiens	Residual Activity	%	2.0
	12246329	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	23.0	CHEMBL3125	Homo sapiens	Residual Activity	%	23.0
	12246330	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	87.0	CHEMBL3125	Homo sapiens	Residual Activity	%	87.0
	12246331	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	80.0	CHEMBL3125	Homo sapiens	Residual Activity	%	80.0
	12246332	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	94.0	CHEMBL3125	Homo sapiens	Residual Activity	%	94.0
	12246333	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	61.0	CHEMBL3125	Homo sapiens	Residual Activity	%	61.0
	12246334	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	108.0	CHEMBL3125	Homo sapiens	Residual Activity	%	108.0
	12246335	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	98.0	CHEMBL3125	Homo sapiens	Residual Activity	%	98.0
	12246336	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	39.0	CHEMBL3125	Homo sapiens	Residual Activity	%	39.0
	12246337	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	83.0	CHEMBL3125	Homo sapiens	Residual Activity	%	83.0
	12246338	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	20.0	CHEMBL3125	Homo sapiens	Residual Activity	%	20.0
	12246339	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	66.0	CHEMBL3125	Homo sapiens	Residual Activity	%	66.0
	12246340	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	86.0	CHEMBL3125	Homo sapiens	Residual Activity	%	86.0
	12246341	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	95.0	CHEMBL3125	Homo sapiens	Residual Activity	%	95.0
	12246342	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	106.0	CHEMBL3125	Homo sapiens	Residual Activity	%	106.0
	12246343	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	110.0	CHEMBL3125	Homo sapiens	Residual Activity	%	110.0
	12246344	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	95.0	CHEMBL3125	Homo sapiens	Residual Activity	%	95.0
	12246345	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	91.0	CHEMBL3125	Homo sapiens	Residual Activity	%	91.0
	12246346	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	84.0	CHEMBL3125	Homo sapiens	Residual Activity	%	84.0
	12246347	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	12.0	CHEMBL3125	Homo sapiens	Residual Activity	%	12.0
	12246348	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	91.0	CHEMBL3125	Homo sapiens	Residual Activity	%	91.0
	12246349	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	88.0	CHEMBL3125	Homo sapiens	Residual Activity	%	88.0
	12246350	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	108.0	CHEMBL3125	Homo sapiens	Residual Activity	%	108.0
	12246351	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	87.0	CHEMBL3125	Homo sapiens	Residual Activity	%	87.0
	12246352	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	92.0	CHEMBL3125	Homo sapiens	Residual Activity	%	92.0
	12246353	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	93.0	CHEMBL3125	Homo sapiens	Residual Activity	%	93.0
	12246354	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	89.0	CHEMBL3125	Homo sapiens	Residual Activity	%	89.0
	12246355	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	89.0	CHEMBL3125	Homo sapiens	Residual Activity	%	89.0
	12246356	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	92.0	CHEMBL3125	Homo sapiens	Residual Activity	%	92.0
	12246357	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	89.0	CHEMBL3125	Homo sapiens	Residual Activity	%	89.0
	12246358	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	18.0	CHEMBL3125	Homo sapiens	Residual Activity	%	18.0
	12246359	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	99.0	CHEMBL3125	Homo sapiens	Residual Activity	%	99.0
	12246360	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	95.0	CHEMBL3125	Homo sapiens	Residual Activity	%	95.0
	12246361	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	102.0	CHEMBL3125	Homo sapiens	Residual Activity	%	102.0
	12246362	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	105.0	CHEMBL3125	Homo sapiens	Residual Activity	%	105.0
	12246363	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	42.0	CHEMBL3125	Homo sapiens	Residual Activity	%	42.0
	12246364	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	83.0	CHEMBL3125	Homo sapiens	Residual Activity	%	83.0
	12246365	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	1.0	CHEMBL3125	Homo sapiens	Residual Activity	%	1.0
	12246366	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	97.0	CHEMBL3125	Homo sapiens	Residual Activity	%	97.0
	12249032	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	87.0	CHEMBL3125	Homo sapiens	Residual Activity	%	87.0
	12249033	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	87.0	CHEMBL3125	Homo sapiens	Residual Activity	%	87.0
	12249034	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	82.0	CHEMBL3125	Homo sapiens	Residual Activity	%	82.0
	12249035	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	107.0	CHEMBL3125	Homo sapiens	Residual Activity	%	107.0
	12249036	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	110.0	CHEMBL3125	Homo sapiens	Residual Activity	%	110.0
	12249037	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	100.0	CHEMBL3125	Homo sapiens	Residual Activity	%	100.0
	12249038	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	102.0	CHEMBL3125	Homo sapiens	Residual Activity	%	102.0
	12249039	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	95.0	CHEMBL3125	Homo sapiens	Residual Activity	%	95.0
	12249040	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	32.0	CHEMBL3125	Homo sapiens	Residual Activity	%	32.0
	12249041	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	100.0	CHEMBL3125	Homo sapiens	Residual Activity	%	100.0
	12249042	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	93.0	CHEMBL3125	Homo sapiens	Residual Activity	%	93.0
	12249043	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	59.0	CHEMBL3125	Homo sapiens	Residual Activity	%	59.0
	12249044	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	105.0	CHEMBL3125	Homo sapiens	Residual Activity	%	105.0
	12249045	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	97.0	CHEMBL3125	Homo sapiens	Residual Activity	%	97.0
	12249046	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	58.0	CHEMBL3125	Homo sapiens	Residual Activity	%	58.0
	12249047	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	95.0	CHEMBL3125	Homo sapiens	Residual Activity	%	95.0
	12249048	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	105.0	CHEMBL3125	Homo sapiens	Residual Activity	%	105.0
	12249049	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	96.0	CHEMBL3125	Homo sapiens	Residual Activity	%	96.0
	12249050	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	92.0	CHEMBL3125	Homo sapiens	Residual Activity	%	92.0
	12249051	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	53.0	CHEMBL3125	Homo sapiens	Residual Activity	%	53.0
	12249052	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	-1.0	CHEMBL3125	Homo sapiens	Residual Activity	%	-1.0
	12249053	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	94.0	CHEMBL3125	Homo sapiens	Residual Activity	%	94.0
	12249054	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	56.0	CHEMBL3125	Homo sapiens	Residual Activity	%	56.0
	12249055	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	96.0	CHEMBL3125	Homo sapiens	Residual Activity	%	96.0
	12249056	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	102.0	CHEMBL3125	Homo sapiens	Residual Activity	%	102.0
	12249057	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	94.0	CHEMBL3125	Homo sapiens	Residual Activity	%	94.0
	12249058	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	97.0	CHEMBL3125	Homo sapiens	Residual Activity	%	97.0
	12249059	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	96.0	CHEMBL3125	Homo sapiens	Residual Activity	%	96.0
	12249060	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	82.0	CHEMBL3125	Homo sapiens	Residual Activity	%	82.0
	12249061	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	87.0	CHEMBL3125	Homo sapiens	Residual Activity	%	87.0
	12249062	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	103.0	CHEMBL3125	Homo sapiens	Residual Activity	%	103.0
	12249063	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	88.0	CHEMBL3125	Homo sapiens	Residual Activity	%	88.0
	12249064	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	92.0	CHEMBL3125	Homo sapiens	Residual Activity	%	92.0
	12249065	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	94.0	CHEMBL3125	Homo sapiens	Residual Activity	%	94.0
	12249066	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	96.0	CHEMBL3125	Homo sapiens	Residual Activity	%	96.0
	12249067	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	85.0	CHEMBL3125	Homo sapiens	Residual Activity	%	85.0
	12249068	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	96.0	CHEMBL3125	Homo sapiens	Residual Activity	%	96.0
	12249069	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	97.0	CHEMBL3125	Homo sapiens	Residual Activity	%	97.0
	12249070	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	95.0	CHEMBL3125	Homo sapiens	Residual Activity	%	95.0
	12249071	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	90.0	CHEMBL3125	Homo sapiens	Residual Activity	%	90.0
	12249072	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	79.0	CHEMBL3125	Homo sapiens	Residual Activity	%	79.0
	12249073	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	57.0	CHEMBL3125	Homo sapiens	Residual Activity	%	57.0
	12249074	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	65.0	CHEMBL3125	Homo sapiens	Residual Activity	%	65.0
	12249075	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	15.0	CHEMBL3125	Homo sapiens	Residual Activity	%	15.0
	12249076	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	102.0	CHEMBL3125	Homo sapiens	Residual Activity	%	102.0
	12249077	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	95.0	CHEMBL3125	Homo sapiens	Residual Activity	%	95.0
	12249078	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	109.0	CHEMBL3125	Homo sapiens	Residual Activity	%	109.0
	12249079	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	95.0	CHEMBL3125	Homo sapiens	Residual Activity	%	95.0
	12249080	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	19.0	CHEMBL3125	Homo sapiens	Residual Activity	%	19.0
	12249081	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	88.0	CHEMBL3125	Homo sapiens	Residual Activity	%	88.0
	12249082	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	88.0	CHEMBL3125	Homo sapiens	Residual Activity	%	88.0
	12249083	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	76.0	CHEMBL3125	Homo sapiens	Residual Activity	%	76.0
	12249084	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	96.0	CHEMBL3125	Homo sapiens	Residual Activity	%	96.0
	12249085	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	90.0	CHEMBL3125	Homo sapiens	Residual Activity	%	90.0
	12249086	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	108.0	CHEMBL3125	Homo sapiens	Residual Activity	%	108.0
	12249087	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	102.0	CHEMBL3125	Homo sapiens	Residual Activity	%	102.0
	12249088	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	64.0	CHEMBL3125	Homo sapiens	Residual Activity	%	64.0
	12249089	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	60.0	CHEMBL3125	Homo sapiens	Residual Activity	%	60.0
	12249090	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	93.0	CHEMBL3125	Homo sapiens	Residual Activity	%	93.0
	12249091	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	97.0	CHEMBL3125	Homo sapiens	Residual Activity	%	97.0
	12249092	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	9.0	CHEMBL3125	Homo sapiens	Residual Activity	%	9.0
	12249093	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	95.0	CHEMBL3125	Homo sapiens	Residual Activity	%	95.0
	12249094	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	103.0	CHEMBL3125	Homo sapiens	Residual Activity	%	103.0
	12249095	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	109.0	CHEMBL3125	Homo sapiens	Residual Activity	%	109.0
	12249096	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	94.0	CHEMBL3125	Homo sapiens	Residual Activity	%	94.0
	12249097	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	100.0	CHEMBL3125	Homo sapiens	Residual Activity	%	100.0
	12249098	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	104.0	CHEMBL3125	Homo sapiens	Residual Activity	%	104.0
	12249099	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	92.0	CHEMBL3125	Homo sapiens	Residual Activity	%	92.0
	12249100	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	95.0	CHEMBL3125	Homo sapiens	Residual Activity	%	95.0
	12249101	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	63.0	CHEMBL3125	Homo sapiens	Residual Activity	%	63.0
	12249102	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	102.0	CHEMBL3125	Homo sapiens	Residual Activity	%	102.0
	12249103	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	97.0	CHEMBL3125	Homo sapiens	Residual Activity	%	97.0
	12249104	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	109.0	CHEMBL3125	Homo sapiens	Residual Activity	%	109.0
	12249105	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	113.0	CHEMBL3125	Homo sapiens	Residual Activity	%	113.0
	12249106	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	92.0	CHEMBL3125	Homo sapiens	Residual Activity	%	92.0
	12249107	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	77.0	CHEMBL3125	Homo sapiens	Residual Activity	%	77.0
	12249108	CHEMBL2219281	Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	5.0	CHEMBL3125	Homo sapiens	Residual Activity	%	5.0
	12249109	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	92.0	CHEMBL3125	Homo sapiens	Residual Activity	%	92.0
	12249110	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	6.0	CHEMBL3125	Homo sapiens	Residual Activity	%	6.0
	12249111	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	101.0	CHEMBL3125	Homo sapiens	Residual Activity	%	101.0
	12249112	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	95.0	CHEMBL3125	Homo sapiens	Residual Activity	%	95.0
	12249113	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	109.0	CHEMBL3125	Homo sapiens	Residual Activity	%	109.0
	12249114	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	86.0	CHEMBL3125	Homo sapiens	Residual Activity	%	86.0
	12249115	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	41.0	CHEMBL3125	Homo sapiens	Residual Activity	%	41.0
	12249116	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	83.0	CHEMBL3125	Homo sapiens	Residual Activity	%	83.0
	12249117	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	108.0	CHEMBL3125	Homo sapiens	Residual Activity	%	108.0
	12249118	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	102.0	CHEMBL3125	Homo sapiens	Residual Activity	%	102.0
	12249119	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	105.0	CHEMBL3125	Homo sapiens	Residual Activity	%	105.0
	12249120	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	103.0	CHEMBL3125	Homo sapiens	Residual Activity	%	103.0
	12249121	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	116.0	CHEMBL3125	Homo sapiens	Residual Activity	%	116.0
	12249122	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	81.0	CHEMBL3125	Homo sapiens	Residual Activity	%	81.0
	12249123	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	81.0	CHEMBL3125	Homo sapiens	Residual Activity	%	81.0
	12249124	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	91.0	CHEMBL3125	Homo sapiens	Residual Activity	%	91.0
	12249125	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	96.0	CHEMBL3125	Homo sapiens	Residual Activity	%	96.0
	12249126	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	94.0	CHEMBL3125	Homo sapiens	Residual Activity	%	94.0
	12249127	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	99.0	CHEMBL3125	Homo sapiens	Residual Activity	%	99.0
	12249128	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	44.0	CHEMBL3125	Homo sapiens	Residual Activity	%	44.0
	12249129	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	99.0	CHEMBL3125	Homo sapiens	Residual Activity	%	99.0
	12249130	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	91.0	CHEMBL3125	Homo sapiens	Residual Activity	%	91.0
	12249131	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	101.0	CHEMBL3125	Homo sapiens	Residual Activity	%	101.0
	12249132	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	101.0	CHEMBL3125	Homo sapiens	Residual Activity	%	101.0
	12249133	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	111.0	CHEMBL3125	Homo sapiens	Residual Activity	%	111.0
	12249134	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	88.0	CHEMBL3125	Homo sapiens	Residual Activity	%	88.0
	12249135	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	27.0	CHEMBL3125	Homo sapiens	Residual Activity	%	27.0
	12249136	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	72.0	CHEMBL3125	Homo sapiens	Residual Activity	%	72.0
	12249137	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	123.0	CHEMBL3125	Homo sapiens	Residual Activity	%	123.0
	12249138	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	4.0	CHEMBL3125	Homo sapiens	Residual Activity	%	4.0
	12249139	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	108.0	CHEMBL3125	Homo sapiens	Residual Activity	%	108.0
	12249140	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	93.0	CHEMBL3125	Homo sapiens	Residual Activity	%	93.0
	12249141	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	96.0	CHEMBL3125	Homo sapiens	Residual Activity	%	96.0
	12249142	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	105.0	CHEMBL3125	Homo sapiens	Residual Activity	%	105.0
	12249143	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	104.0	CHEMBL3125	Homo sapiens	Residual Activity	%	104.0
	12249144	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	104.0	CHEMBL3125	Homo sapiens	Residual Activity	%	104.0
	12249145	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	93.0	CHEMBL3125	Homo sapiens	Residual Activity	%	93.0
	12249146	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	105.0	CHEMBL3125	Homo sapiens	Residual Activity	%	105.0
	12249147	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	104.0	CHEMBL3125	Homo sapiens	Residual Activity	%	104.0
	12249148	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	99.0	CHEMBL3125	Homo sapiens	Residual Activity	%	99.0
	12249149	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	116.0	CHEMBL3125	Homo sapiens	Residual Activity	%	116.0
	12249150	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	109.0	CHEMBL3125	Homo sapiens	Residual Activity	%	109.0
	12249151	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	5.0	CHEMBL3125	Homo sapiens	Residual Activity	%	5.0
	12249152	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	4.0	CHEMBL3125	Homo sapiens	Residual Activity	%	4.0
	12249153	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	93.0	CHEMBL3125	Homo sapiens	Residual Activity	%	93.0
	12249154	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	54.0	CHEMBL3125	Homo sapiens	Residual Activity	%	54.0
	12249155	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	101.0	CHEMBL3125	Homo sapiens	Residual Activity	%	101.0
	12249156	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	39.0	CHEMBL3125	Homo sapiens	Residual Activity	%	39.0
	12249157	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	108.0	CHEMBL3125	Homo sapiens	Residual Activity	%	108.0
	12249158	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	103.0	CHEMBL3125	Homo sapiens	Residual Activity	%	103.0
	12249159	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	5.0	CHEMBL3125	Homo sapiens	Residual Activity	%	5.0
	12249160	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	59.0	CHEMBL3125	Homo sapiens	Residual Activity	%	59.0
	12249161	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	6.0	CHEMBL3125	Homo sapiens	Residual Activity	%	6.0
	12249162	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	37.0	CHEMBL3125	Homo sapiens	Residual Activity	%	37.0
	12249163	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	74.0	CHEMBL3125	Homo sapiens	Residual Activity	%	74.0
	12249164	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	95.0	CHEMBL3125	Homo sapiens	Residual Activity	%	95.0
	12249165	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	101.0	CHEMBL3125	Homo sapiens	Residual Activity	%	101.0
	12249166	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	97.0	CHEMBL3125	Homo sapiens	Residual Activity	%	97.0
	12249167	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	70.0	CHEMBL3125	Homo sapiens	Residual Activity	%	70.0
	12249168	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	97.0	CHEMBL3125	Homo sapiens	Residual Activity	%	97.0
	12249169	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	51.0	CHEMBL3125	Homo sapiens	Residual Activity	%	51.0
	12249170	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	8.0	CHEMBL3125	Homo sapiens	Residual Activity	%	8.0
	12249171	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	85.0	CHEMBL3125	Homo sapiens	Residual Activity	%	85.0
	12249172	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	100.0	CHEMBL3125	Homo sapiens	Residual Activity	%	100.0
	12249173	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	123.0	CHEMBL3125	Homo sapiens	Residual Activity	%	123.0
	12249174	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	57.0	CHEMBL3125	Homo sapiens	Residual Activity	%	57.0
	12249175	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	104.0	CHEMBL3125	Homo sapiens	Residual Activity	%	104.0
	12249176	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	103.0	CHEMBL3125	Homo sapiens	Residual Activity	%	103.0
	12249177	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	68.0	CHEMBL3125	Homo sapiens	Residual Activity	%	68.0
	12249178	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	135.0	CHEMBL3125	Homo sapiens	Residual Activity	%	135.0
	12249179	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	103.0	CHEMBL3125	Homo sapiens	Residual Activity	%	103.0
	12249180	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	89.0	CHEMBL3125	Homo sapiens	Residual Activity	%	89.0
	12249181	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	3.0	CHEMBL3125	Homo sapiens	Residual Activity	%	3.0
	12249182	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	101.0	CHEMBL3125	Homo sapiens	Residual Activity	%	101.0
	12249183	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	98.0	CHEMBL3125	Homo sapiens	Residual Activity	%	98.0
	12249184	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	108.0	CHEMBL3125	Homo sapiens	Residual Activity	%	108.0
	12249185	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	97.0	CHEMBL3125	Homo sapiens	Residual Activity	%	97.0
	12249186	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	15.0	CHEMBL3125	Homo sapiens	Residual Activity	%	15.0
	12249187	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	88.0	CHEMBL3125	Homo sapiens	Residual Activity	%	88.0
	12249188	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	-1.0	CHEMBL3125	Homo sapiens	Residual Activity	%	-1.0
	12249189	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	86.0	CHEMBL3125	Homo sapiens	Residual Activity	%	86.0
	12249190	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	43.0	CHEMBL3125	Homo sapiens	Residual Activity	%	43.0
	12249191	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	76.0	CHEMBL3125	Homo sapiens	Residual Activity	%	76.0
	12249192	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	58.0	CHEMBL3125	Homo sapiens	Residual Activity	%	58.0
	12249193	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	94.0	CHEMBL3125	Homo sapiens	Residual Activity	%	94.0
	12249194	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	100.0	CHEMBL3125	Homo sapiens	Residual Activity	%	100.0
	12249195	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	84.0	CHEMBL3125	Homo sapiens	Residual Activity	%	84.0
	12249196	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	81.0	CHEMBL3125	Homo sapiens	Residual Activity	%	81.0
	12249197	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	90.0	CHEMBL3125	Homo sapiens	Residual Activity	%	90.0
	12249198	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	4.0	CHEMBL3125	Homo sapiens	Residual Activity	%	4.0
	12249199	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	89.0	CHEMBL3125	Homo sapiens	Residual Activity	%	89.0
	12249200	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	78.0	CHEMBL3125	Homo sapiens	Residual Activity	%	78.0
	12249201	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	14.0	CHEMBL3125	Homo sapiens	Residual Activity	%	14.0
	12249202	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	97.0	CHEMBL3125	Homo sapiens	Residual Activity	%	97.0
	12249203	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	86.0	CHEMBL3125	Homo sapiens	Residual Activity	%	86.0
	12249204	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	21.0	CHEMBL3125	Homo sapiens	Residual Activity	%	21.0
	12249205	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	94.0	CHEMBL3125	Homo sapiens	Residual Activity	%	94.0
	12249206	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	99.0	CHEMBL3125	Homo sapiens	Residual Activity	%	99.0
	12249207	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	90.0	CHEMBL3125	Homo sapiens	Residual Activity	%	90.0
	12249208	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	87.0	CHEMBL3125	Homo sapiens	Residual Activity	%	87.0
	12249209	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	29.0	CHEMBL3125	Homo sapiens	Residual Activity	%	29.0
	12249210	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	0.0	CHEMBL3125	Homo sapiens	Residual Activity	%	0.0
	12249211	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	98.0	CHEMBL3125	Homo sapiens	Residual Activity	%	98.0
	12249212	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	64.0	CHEMBL3125	Homo sapiens	Residual Activity	%	64.0
	12249213	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	102.0	CHEMBL3125	Homo sapiens	Residual Activity	%	102.0
	12249214	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	97.0	CHEMBL3125	Homo sapiens	Residual Activity	%	97.0
	12249215	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	81.0	CHEMBL3125	Homo sapiens	Residual Activity	%	81.0
	12249216	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	90.0	CHEMBL3125	Homo sapiens	Residual Activity	%	90.0
	12249217	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	94.0	CHEMBL3125	Homo sapiens	Residual Activity	%	94.0
	12249218	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	63.0	CHEMBL3125	Homo sapiens	Residual Activity	%	63.0
	12249219	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	85.0	CHEMBL3125	Homo sapiens	Residual Activity	%	85.0
	12249220	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	77.0	CHEMBL3125	Homo sapiens	Residual Activity	%	77.0
	12249221	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	79.0	CHEMBL3125	Homo sapiens	Residual Activity	%	79.0
	12249222	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	59.0	CHEMBL3125	Homo sapiens	Residual Activity	%	59.0
	12249223	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	102.0	CHEMBL3125	Homo sapiens	Residual Activity	%	102.0
	12249224	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	85.0	CHEMBL3125	Homo sapiens	Residual Activity	%	85.0
	12249225	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	46.0	CHEMBL3125	Homo sapiens	Residual Activity	%	46.0
	12249226	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	85.0	CHEMBL3125	Homo sapiens	Residual Activity	%	85.0
	12249227	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	79.0	CHEMBL3125	Homo sapiens	Residual Activity	%	79.0
	12249228	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	85.0	CHEMBL3125	Homo sapiens	Residual Activity	%	85.0
	12249229	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	85.0	CHEMBL3125	Homo sapiens	Residual Activity	%	85.0
	12249230	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	60.0	CHEMBL3125	Homo sapiens	Residual Activity	%	60.0
	12249231	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	37.0	CHEMBL3125	Homo sapiens	Residual Activity	%	37.0
	12249232	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	53.0	CHEMBL3125	Homo sapiens	Residual Activity	%	53.0
	12249233	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	2.0	CHEMBL3125	Homo sapiens	Residual Activity	%	2.0
	12249234	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	89.0	CHEMBL3125	Homo sapiens	Residual Activity	%	89.0
	12249235	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	62.0	CHEMBL3125	Homo sapiens	Residual Activity	%	62.0
	12249236	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	94.0	CHEMBL3125	Homo sapiens	Residual Activity	%	94.0
	12249237	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	98.0	CHEMBL3125	Homo sapiens	Residual Activity	%	98.0
	12249238	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	21.0	CHEMBL3125	Homo sapiens	Residual Activity	%	21.0
	12249239	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	82.0	CHEMBL3125	Homo sapiens	Residual Activity	%	82.0
	12249240	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	91.0	CHEMBL3125	Homo sapiens	Residual Activity	%	91.0
	12249241	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	36.0	CHEMBL3125	Homo sapiens	Residual Activity	%	36.0
	12249242	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	91.0	CHEMBL3125	Homo sapiens	Residual Activity	%	91.0
	12249243	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	68.0	CHEMBL3125	Homo sapiens	Residual Activity	%	68.0
	12249244	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	51.0	CHEMBL3125	Homo sapiens	Residual Activity	%	51.0
	12249245	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	81.0	CHEMBL3125	Homo sapiens	Residual Activity	%	81.0
	12249246	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	23.0	CHEMBL3125	Homo sapiens	Residual Activity	%	23.0
	12249247	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	55.0	CHEMBL3125	Homo sapiens	Residual Activity	%	55.0
	12249248	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	79.0	CHEMBL3125	Homo sapiens	Residual Activity	%	79.0
	12249249	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	84.0	CHEMBL3125	Homo sapiens	Residual Activity	%	84.0
	12249250	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	2.0	CHEMBL3125	Homo sapiens	Residual Activity	%	2.0
	12249251	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	84.0	CHEMBL3125	Homo sapiens	Residual Activity	%	84.0
	12249252	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	70.0	CHEMBL3125	Homo sapiens	Residual Activity	%	70.0
	12249253	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	84.0	CHEMBL3125	Homo sapiens	Residual Activity	%	84.0
	12249254	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	84.0	CHEMBL3125	Homo sapiens	Residual Activity	%	84.0
	12249255	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	74.0	CHEMBL3125	Homo sapiens	Residual Activity	%	74.0
	12249256	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	67.0	CHEMBL3125	Homo sapiens	Residual Activity	%	67.0
	12249257	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	74.0	CHEMBL3125	Homo sapiens	Residual Activity	%	74.0
	12249258	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	84.0	CHEMBL3125	Homo sapiens	Residual Activity	%	84.0
	12249259	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	19.0	CHEMBL3125	Homo sapiens	Residual Activity	%	19.0
	12249260	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	64.0	CHEMBL3125	Homo sapiens	Residual Activity	%	64.0
	12249261	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	84.0	CHEMBL3125	Homo sapiens	Residual Activity	%	84.0
	12249262	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	89.0	CHEMBL3125	Homo sapiens	Residual Activity	%	89.0
	12249263	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	99.0	CHEMBL3125	Homo sapiens	Residual Activity	%	99.0
	12249264	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	72.0	CHEMBL3125	Homo sapiens	Residual Activity	%	72.0
	12249265	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	43.0	CHEMBL3125	Homo sapiens	Residual Activity	%	43.0
	12249266	CHEMBL2219282	Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	2.0	CHEMBL3125	Homo sapiens	Residual Activity	%	2.0
	12660674	CHEMBL2330663	Inhibition of MSK2 (unknown origin) at 1 uM	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Inhibition	%	75.0	CHEMBL3125	Homo sapiens	INH	%	75.0
	12727724	CHEMBL2351158	Inhibition of MSK2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	88.0	CHEMBL3125	Homo sapiens	Activity	%	88.0
	12729012	CHEMBL2350436	Inhibition of MSK2 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	92.0	CHEMBL3125	Homo sapiens	Activity	%	92.0
	12729896	CHEMBL2349799	Inhibition of MSK2 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	98.0	CHEMBL3125	Homo sapiens	Activity	%	98.0
	12730155	CHEMBL2351158	Inhibition of MSK2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	94.0	CHEMBL3125	Homo sapiens	Activity	%	94.0
	13352093	CHEMBL2399031	Inhibition of MSK2 (unknown origin)	B	Cc1nc(NC(=O)C(C)(C)CC(F)(F)F)sc1-c1ccc(N)nc1		CHEMBL2397316	=	IC50	nM	4600.0	CHEMBL3125	Homo sapiens	IC50	uM	4.6
	13374354	CHEMBL2406298	Inhibition of MSK2 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	5.0	CHEMBL3125	Homo sapiens	INH	%	5.0
	13419766	CHEMBL2422288	Inhibition of MSK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	52.0	CHEMBL3125	Homo sapiens	INH	%	52.0
	13419767	CHEMBL2422288	Inhibition of MSK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	100.0	CHEMBL3125	Homo sapiens	INH	%	100.0
	13419768	CHEMBL2422288	Inhibition of MSK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	94.0	CHEMBL3125	Homo sapiens	INH	%	94.0
	13439756	CHEMBL2428997	Competitive binding affinity to RPS6KA4 kinase domain 2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL3125	Homo sapiens	INH	%	50.0
	13439757	CHEMBL2428998	Competitive binding affinity to RPS6KA4 kinase domain 1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL3125	Homo sapiens	INH	%	50.0
	13442609	CHEMBL2428998	Competitive binding affinity to RPS6KA4 kinase domain 1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	99.0	CHEMBL3125	Homo sapiens	INH	%	99.0
	13445589	CHEMBL2428997	Competitive binding affinity to RPS6KA4 kinase domain 2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL3125	Homo sapiens	INH	%	50.0
	13445590	CHEMBL2428998	Competitive binding affinity to RPS6KA4 kinase domain 1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL3125	Homo sapiens	INH	%	50.0
	13451576	CHEMBL2428997	Competitive binding affinity to RPS6KA4 kinase domain 2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	94.0	CHEMBL3125	Homo sapiens	INH	%	94.0
	13451577	CHEMBL2428998	Competitive binding affinity to RPS6KA4 kinase domain 1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL3125	Homo sapiens	INH	%	50.0
	13871750	CHEMBL3100786	Inhibition of human Rsk4 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	122.0	CHEMBL3125	Homo sapiens	Activity	%	122.0
	13872088	CHEMBL3101273	Inhibition of human MSK2 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	78.0	CHEMBL3125	Homo sapiens	Activity	%	78.0
	13966054	CHEMBL3136791	Inhibition of human full length MSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	81.0	CHEMBL3125	Homo sapiens	INH	%	81.0
	13973329	CHEMBL3135067	Inhibition of human full length MSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	13.5	CHEMBL3125	Homo sapiens	INH	%	13.5
	13974047	CHEMBL3136639	Inhibition of human full length MSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	0.0	CHEMBL3125	Homo sapiens	INH	%	0.0
	13974138	CHEMBL3136352	Inhibition of human full length MSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	52.0	CHEMBL3125	Homo sapiens	INH	%	52.0
	13974229	CHEMBL3135454	Inhibition of human full length MSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	69.5	CHEMBL3125	Homo sapiens	INH	%	69.5
	13974967	CHEMBL3136989	Inhibition of human full length MSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	76.0	CHEMBL3125	Homo sapiens	INH	%	76.0
	13975058	CHEMBL3136582	Inhibition of human full length MSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	3.5	CHEMBL3125	Homo sapiens	INH	%	3.5
	13975149	CHEMBL3134754	Inhibition of human full length MSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	0.0	CHEMBL3125	Homo sapiens	INH	%	0.0
	13975240	CHEMBL3136521	Inhibition of human full length MSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	15.0	CHEMBL3125	Homo sapiens	INH	%	15.0
	13975883	CHEMBL3135654	Inhibition of human full length MSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	50.0	CHEMBL3125	Homo sapiens	INH	%	50.0
	13975976	CHEMBL3136173	Inhibition of human full length MSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	82.5	CHEMBL3125	Homo sapiens	INH	%	82.5
	13976067	CHEMBL3136051	Inhibition of human full length MSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	54.0	CHEMBL3125	Homo sapiens	INH	%	54.0
	13976158	CHEMBL3135095	Inhibition of human full length MSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	68.0	CHEMBL3125	Homo sapiens	INH	%	68.0
	14582559	CHEMBL3241623	Inhibition of human MSK2 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	111.0	CHEMBL3125	Homo sapiens	Activity	%	111.0
	14585327	CHEMBL3241843	Inhibition of human Rsk4 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	120.5	CHEMBL3125	Homo sapiens	Activity	%	120.5
	15018642	CHEMBL3361534	Inhibition of MSK2 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	16.1	CHEMBL3125	Homo sapiens	INH	%	16.1
	15756902	CHEMBL3631454	Inhibition of MSK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	70.45	CHEMBL3125	Homo sapiens	INH	%	70.45
	15757821	CHEMBL3631454	Inhibition of MSK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	19.49	CHEMBL3125	Homo sapiens	INH	%	19.49
	15758800	CHEMBL3631454	Inhibition of MSK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	4.4	CHEMBL3125	Homo sapiens	INH	%	4.4
	16431916	CHEMBL3748009	Inhibition of human MSK2 using [GRPRTSSFAEG] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL3125	Homo sapiens	IC50	uM	10.0
	16451523	CHEMBL3760646	Inhibition of MSK2 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	15.2	CHEMBL3125	Homo sapiens	INH	%	15.2
	16474702	CHEMBL3767322	Inhibition of MSK2 (unknown origin) at 10 uM	B	CN1CCN(CCCOc2ccc(N3C(=O)/C(=C/c4ccc(Oc5ccc(F)cc5)cc4)SC3=S)cc2)CC1		CHEMBL3765499	=	Inhibition	%	0.0	CHEMBL3125	Homo sapiens	INH	%	0.0
	16495139	CHEMBL3777718	Inhibition of N-terminal His6-tagged recombinant human MSK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-2.0	CHEMBL3125	Homo sapiens	Activity	%	-2.0
	16496058	CHEMBL3777718	Inhibition of N-terminal His6-tagged recombinant human MSK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-3.0	CHEMBL3125	Homo sapiens	Activity	%	-3.0
	16508245	CHEMBL3777718	Inhibition of N-terminal His6-tagged recombinant human MSK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-20.0	CHEMBL3125	Homo sapiens	Activity	%	-20.0
	16614550	CHEMBL3817581	Inhibition of human MSK2 at 1 uM using [GRPRTSSFAEG] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	-4.0	CHEMBL3125	Homo sapiens	INH	%	-4.0
	16618159	CHEMBL3817272	Inhibition of full length recombinant human GST-tagged MSK2 expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL3125	Homo sapiens	INH	%	50.0
Inactive	17936710	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936711	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936712	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936713	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936714	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936715	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936716	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936717	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936718	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17936719	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	=	Kd	nM	3407.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	3407.0
Active	17936720	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	851.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	851.0
Inactive	17936721	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936722	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936723	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Active	17936724	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	111.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	111.0
Inactive	17936725	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936726	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936727	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936728	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936729	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936730	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936731	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936732	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Active	17936733	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	432.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	432.0
Inactive	17936734	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936735	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936736	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936737	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936738	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936739	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936740	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936741	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936742	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936743	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936744	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936745	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936746	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936747	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936748	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936749	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936750	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936751	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936752	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936753	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936754	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936755	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936756	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936757	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Active	17936758	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	3004.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	3004.0
Inactive	17936759	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936760	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936761	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936762	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936763	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936764	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936765	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936766	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936767	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936768	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936769	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936770	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936771	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936772	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936773	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936774	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936775	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936776	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936777	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936778	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936779	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936780	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Active	17936781	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	572.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	572.0
Inactive	17936782	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936783	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936784	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936785	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936786	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936787	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936788	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936789	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936790	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17936791	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	=	Kd	nM	2455.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	2455.0
Inactive	17936792	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936793	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936794	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936795	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936796	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936797	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936798	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936799	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936800	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Active	17936801	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Kd	nM	156.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	156.0
Inactive	17936802	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936803	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936804	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936805	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Active	17936806	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	420.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	420.0
Inactive	17936807	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936808	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936809	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936810	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936811	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936812	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936813	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936814	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936815	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936816	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Active	17936817	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	73.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	73.0
Inactive	17936818	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936819	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936820	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936821	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936822	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936823	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936824	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936825	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936826	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936827	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936828	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936829	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936830	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936831	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936832	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936833	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936834	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936835	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936836	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936837	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936838	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936839	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936840	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936841	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936842	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936843	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936844	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936845	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936846	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936847	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936848	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936849	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936850	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936851	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Active	17936852	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	=	Kd	nM	879.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	879.0
Inactive	17936853	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936854	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Active	17936855	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Kd	nM	1388.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	1388.0
Inactive	17936856	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936857	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936858	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936859	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936860	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936861	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936862	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936863	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936864	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936865	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936866	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936867	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936868	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936869	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936870	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Active	17936871	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	=	Kd	nM	499.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	499.0
Inactive	17936872	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936873	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936874	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936875	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936876	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936877	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936878	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936879	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936880	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936881	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936882	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936883	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Active	17936884	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	6381.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	6381.0
Inactive	17936885	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936886	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Active	17936887	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	=	Kd	nM	2069.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	2069.0
Inactive	17936888	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936889	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936890	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936891	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936892	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936893	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936894	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936895	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936896	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936897	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936898	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936899	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936900	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936901	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936902	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936903	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936904	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936905	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936906	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936907	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936908	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936909	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936910	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936911	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Active	17936912	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	=	Kd	nM	1459.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	1459.0
Inactive	17936913	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936914	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936915	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936916	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936917	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936918	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936919	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936920	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Active	17936921	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	324.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	324.0
Active	17936922	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	272.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	272.0
Inactive	17936923	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936924	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936925	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936926	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936927	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936928	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936929	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936930	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936931	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Active	17936932	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	=	Kd	nM	1055.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	1055.0
Uncertain	17936933	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	=	Kd	nM	12827.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	12827.0
Inactive	17936934	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936935	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936936	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936937	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936938	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936939	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936940	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936941	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936942	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936943	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936944	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936945	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936946	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936947	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936948	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Active	17936949	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	111.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	111.0
Inactive	17936950	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936951	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17936952	CHEMBL3991874	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL3125	Homo sapiens	Kd apparent	nM	30000.0
	18114838	CHEMBL4025368	Inhibition of wild-type human partial length N-terminal RPS6KA4 kinase domain 1 expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	97.0	CHEMBL3125	Homo sapiens	Activity	%	97.0
	18114839	CHEMBL4025369	Inhibition of wild-type human partial length C-terminal RPS6KA4 kinase domain 2 (M375 to T705 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL3125	Homo sapiens	Activity	%	100.0
	18153271	CHEMBL4034407	Inhibition of MSK2 domain1 Lysine 2 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	-3.7	CHEMBL3125	Homo sapiens	INH	%	-3.7
	18203892	CHEMBL4044179	Inhibition of wild-type human partial length N-terminal RPS6KA4 kinase domain 1 expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	97.0	CHEMBL3125	Homo sapiens	Activity	%	97.0
	18203893	CHEMBL4044180	Inhibition of wild-type human partial length C-terminal RPS6KA4 kinase domain 2 (M375 to T705 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	93.0	CHEMBL3125	Homo sapiens	Activity	%	93.0
	18211551	CHEMBL4045762	Inhibition of MSK2 domain1 conserved Lys2 (DIKLENILLDSNGHVVLTDFGLSK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	10.3	CHEMBL3125	Homo sapiens	INH	%	10.3
	18211907	CHEMBL4046003	Inhibition of MSK2 domain1 conserved Lys2 (DIKLENILLDSNGHVVLTDFGLSK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	31.2	CHEMBL3125	Homo sapiens	INH	%	31.2
	18212132	CHEMBL4046150	Inhibition of MSK2 (unknown origin) at 1 uM relative to control	B	Cc1c(-c2ccncc2)c[nH]c1C(N)=O		CHEMBL4100387	<	Inhibition	%	20.0	CHEMBL3125	Homo sapiens	INH	%	20.0
	18253701	CHEMBL4055135	Inhibition of wild-type human partial length C-terminal MSK2 kinase domain 2 (M375 to T705 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	98.0	CHEMBL3125	Homo sapiens	Activity	%	98.0
	18253702	CHEMBL4055135	Inhibition of wild-type human partial length C-terminal MSK2 kinase domain 2 (M375 to T705 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL3125	Homo sapiens	Activity	%	100.0
	18253875	CHEMBL4055222	Inhibition of wild-type human partial length N-terminal MSK2 kinase domain 1 expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL3125	Homo sapiens	Activity	%	100.0
	18253876	CHEMBL4055222	Inhibition of wild-type human partial length N-terminal MSK2 kinase domain 1 expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL3125	Homo sapiens	Activity	%	100.0
	18265741	CHEMBL4057191	Inhibition of MSK2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	-3.3	CHEMBL3125	Homo sapiens	INH	%	-3.3
	18265957	CHEMBL4057407	Inhibition of MSK2 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	-3.7	CHEMBL3125	Homo sapiens	INH	%	-3.7
	18275103	CHEMBL4118413	Inhibition of MSK2 domain1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKLENVLLDSEGHIVLTDFGLSK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	24.5	CHEMBL3125	Homo sapiens	INH	%	24.5
	18275104	CHEMBL4118413	Inhibition of MSK2 domain1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKLENVLLDSEGHIVLTDFGLSK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	10.4	CHEMBL3125	Homo sapiens	INH	%	10.4
	18275105	CHEMBL4118413	Inhibition of MSK2 domain1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKLENVLLDSEGHIVLTDFGLSK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	39.8	CHEMBL3125	Homo sapiens	INH	%	39.8
Active	18276018	CHEMBL4118978	Binding affinity to RPS6KA4 in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL3125	Homo sapiens	Activity		
	18282678	CHEMBL4120263	Inhibition of MSK2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	-3.3	CHEMBL3125	Homo sapiens	INH	%	-3.3
	18282900	CHEMBL4120485	Inhibition of MSK2 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	-3.3	CHEMBL3125	Homo sapiens	INH	%	-3.3
	18283119	CHEMBL4120704	Inhibition of MSK2 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	4.0	CHEMBL3125	Homo sapiens	INH	%	4.0
	18407918	CHEMBL4151474	Inhibition of human RPS6KA4 (Kin.Dom.2-C-terminal) expressed in mammalian expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay	B	COc1ccc2c(c1)[nH]c1c(CO)nccc12		CHEMBL4066450	=	Activity	%	54.0	CHEMBL3125	Homo sapiens	Activity	%	54.0
	18407959	CHEMBL4151474	Inhibition of human RPS6KA4 (Kin.Dom.2-C-terminal) expressed in mammalian expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay	B	COc1ccc2c(c1)[nH]c1c(C)nc(CO)cc12		CHEMBL4173266	=	Activity	%	1.0	CHEMBL3125	Homo sapiens	Activity	%	1.0
	18408004	CHEMBL4151474	Inhibition of human RPS6KA4 (Kin.Dom.2-C-terminal) expressed in mammalian expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	40.0	CHEMBL3125	Homo sapiens	Activity	%	40.0
	18440434	CHEMBL4157258	Binding affinity to wild-type human partial length N-terminal RPS6KA4 kinase domain 1 expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL3125	Homo sapiens	Activity	%	100.0
	18440435	CHEMBL4157259	Binding affinity to wild-type human partial length C-terminal RPS6KA4 kinase domain 2 (M375 to T705 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL3125	Homo sapiens	Activity	%	100.0
	18484390	CHEMBL4186037	Binding affinity to wild-type human partial length N-terminal RPS6KA4 kinase domain 1 expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL3125	Homo sapiens	Activity	%	100.0
	18484391	CHEMBL4186038	Binding affinity to wild-type human partial length C-terminal RPS6KA4 kinase domain 2 (M375 to T705 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	96.0	CHEMBL3125	Homo sapiens	Activity	%	96.0
	18484874	CHEMBL4186037	Binding affinity to wild-type human partial length N-terminal RPS6KA4 kinase domain 1 expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	95.0	CHEMBL3125	Homo sapiens	Activity	%	95.0
	18484875	CHEMBL4186038	Binding affinity to wild-type human partial length C-terminal RPS6KA4 kinase domain 2 (M375 to T705 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	51.0	CHEMBL3125	Homo sapiens	Activity	%	51.0
	18507693	CHEMBL4191071	Inhibition of recombinant human MSK2 (2 to end residues) at 1 uM using GRPRTSSFAEGKK as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1	Outside typical range	CHEMBL4207014	=	Inhibition	%	-12.0	CHEMBL3125	Homo sapiens	INH	%	-12.0
	18653509	CHEMBL4230149	Inhibition of MSK2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	3.0	CHEMBL3125	Homo sapiens	INH	%	3.0
	18653510	CHEMBL4230149	Inhibition of MSK2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	5.0	CHEMBL3125	Homo sapiens	INH	%	5.0
	18655297	CHEMBL4230938	Binding affinity to wild-type human partial length C-terminal RPS6KA4 kinase domain 2 (M375 to T705 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL3125	Homo sapiens	Activity	%	100.0
	18655298	CHEMBL4230937	Binding affinity to wild-type human partial length N-terminal RPS6KA4 kinase domain 1 expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	82.0	CHEMBL3125	Homo sapiens	Activity	%	82.0
	18665447	CHEMBL4233361	Inhibition of MSK2 (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	1000.0	CHEMBL3125	Homo sapiens	IC50	nM	1000.0
	18674770	CHEMBL4235391	Inhibition of MSK2 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	2000.0	CHEMBL3125	Homo sapiens	Ki	nM	2000.0
Not Determined	18674771	CHEMBL4235391	Inhibition of MSK2 (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525		Ki			CHEMBL3125	Homo sapiens	Ki		
	18674937	CHEMBL4235448	Inhibition of MSK2 (unknown origin) at 1 uM relative to control	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	=	Inhibition	%	86.0	CHEMBL3125	Homo sapiens	INH	%	86.0
	18751050	CHEMBL4263868	Inhibition of MSK2 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	1.0	CHEMBL3125	Homo sapiens	INH	%	1.0
	18752189	CHEMBL4264526	Binding affinity to wild-type human partial length N-terminal RPS6KA4 kinase domain 1 expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	92.0	CHEMBL3125	Homo sapiens	Activity	%	92.0
	18752190	CHEMBL4264527	Binding affinity to wild-type human partial length C-terminal RPS6KA4 kinase domain 2 (M375 to T705 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	65.0	CHEMBL3125	Homo sapiens	Activity	%	65.0
	18858189	CHEMBL4308035	Binding affinity to wild-type human partial length N-terminal RPS6KA4 kinase domain 1 expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	100.0	CHEMBL3125	Homo sapiens	Activity	%	100.0
	18858190	CHEMBL4308036	Binding affinity to wild-type human partial length C-terminal RPS6KA4 kinase domain 2 (M375 to T705 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	74.0	CHEMBL3125	Homo sapiens	Activity	%	74.0
	18892921	CHEMBL4314887	Inhibition of recombinant human MSK2 (2 to end residues) assessed as residual activity at 10 uM using GRPRTSSFAEGKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	120.5	CHEMBL3125	Homo sapiens	Activity	%	120.5
	18938113	CHEMBL4327783	Inhibition of human MSK2 assessed as residual activity at 1 uM using GRPRTSSFAEG as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	103.9	CHEMBL3125	Homo sapiens	Activity	%	103.9
	18938114	CHEMBL4327783	Inhibition of human MSK2 assessed as residual activity at 1 uM using GRPRTSSFAEG as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	100.88	CHEMBL3125	Homo sapiens	Activity	%	100.88
	18938628	CHEMBL4328147	Inhibition of human MSK2 assessed as residual activity at 100 uM using GRPRTSSFAEG as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL3125	Homo sapiens	Activity	%	65.0
	18939008	CHEMBL4328511	Inhibition of human MSK2 using GRPRTSSFAEG as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	11.3	CHEMBL3125	Homo sapiens	IC50	10'-8M	1.13
	18958570	CHEMBL4333621	Binding affinity to wild-type human partial length C-terminal RPS6KA4 kinase domain 2 (M375 to T705 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	79.0	CHEMBL3125	Homo sapiens	Activity	%	79.0
	18958571	CHEMBL4333620	Binding affinity to wild-type human partial length N-terminal RPS6KA4 kinase domain 1 expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	100.0	CHEMBL3125	Homo sapiens	Activity	%	100.0
	18964490	CHEMBL4335185	Inhibition of recombinant human MSK2 (2 to end residues) assessed as residual activity at 1 uM using GRPRTSSFAEGKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	97.0	CHEMBL3125	Homo sapiens	Activity	%	97.0
	18964491	CHEMBL4335185	Inhibition of recombinant human MSK2 (2 to end residues) assessed as residual activity at 1 uM using GRPRTSSFAEGKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	103.0	CHEMBL3125	Homo sapiens	Activity	%	103.0
	18972000	CHEMBL4337010	Inhibition of recombinant human MSK2 (2 to end residues) assessed as residual activity at 10 uM using GRPRTSSFAEGKK as substrate incubated for 40 mins in presence of [gamma-33ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	58.0	CHEMBL3125	Homo sapiens	Activity	%	58.0
	19009356	CHEMBL4345230	Inhibition of human MSK2 expressed in bacteria assessed as enzyme activity at 1 uM by Kinomescan method relative to control	B	Cc1ccc(-n2ccc3c(Nc4cccc(NC(=O)c5ccc(NC(=O)/C=C/CN(C)C)cc5)c4)ncnc32)cc1		CHEMBL4439287	=	Activity	%	100.0	CHEMBL3125	Homo sapiens	Activity	%	100.0
	19009357	CHEMBL4345230	Inhibition of human MSK2 expressed in bacteria assessed as enzyme activity at 1 uM by Kinomescan method relative to control	B	CN(C)C/C=C/C(=O)Nc1ccc(C(=O)Nc2cccc(Nc3cc(-c4c[nH]c5ccccc45)ncn3)c2)cc1		CHEMBL4446338	=	Activity	%	0.1	CHEMBL3125	Homo sapiens	Activity	%	0.1
	19021532	CHEMBL4347754	Inhibition of recombinant human MSK2 at 20 nM using biotinyl-beta amyloid-beta amyloid-beta AAAARARTSSFAEPG after 15 mins by HTRF method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	-2.0	CHEMBL3125	Homo sapiens	INH	%	-2.0
	19021533	CHEMBL4347755	Inhibition of recombinant human MSK2 at 200 nM using biotinyl-beta amyloid-beta amyloid-beta AAAARARTSSFAEPG after 15 mins by HTRF method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	17.0	CHEMBL3125	Homo sapiens	INH	%	17.0
Not Active	19040058	CHEMBL4351962	Inhibition of recombinant human MSK2 (2 to end residues) at 10 uM using GRPRTSSFAEGKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL3125	Homo sapiens	INH		
Active	19041194	CHEMBL4352455	Inhibition of human MSK2 at 10 uM using GRPRTSSFAEG as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL3125	Homo sapiens	INH		
	19059814	CHEMBL4358115	Binding affinity to wild-type human partial length N-terminal RPS6KA4 kinase domain 1 expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL3125	Homo sapiens	Activity	%	100.0
	19059815	CHEMBL4358116	Binding affinity to wild-type human partial length C-terminal RPS6KA4 kinase domain 2 (M375 to T705 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL3125	Homo sapiens	Activity	%	100.0
	19090378	CHEMBL4365952	Inhibition of wild-type human partial length N-terminal RPS6KA4 kinase domain 1 expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL3125	Homo sapiens	Activity	%	100.0
	19090379	CHEMBL4365953	Inhibition of wild-type human partial length C-terminal RPS6KA4 kinase domain 2 (M375 to T705 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL3125	Homo sapiens	Activity	%	100.0
	19092021	CHEMBL4366495	Inhibition of human MSK2 at 100 nM using GRPRTSSFAEG as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1	Outside typical range	CHEMBL4528675	=	Inhibition	%	-12.78	CHEMBL3125	Homo sapiens	INH	%	-12.78
	19144661	CHEMBL4377677	Inhibition of recombinant human MSK2 (2 to end residues) at 1 uM using GRPRTSSFAEGKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	6.0	CHEMBL3125	Homo sapiens	INH	%	6.0
	19146852	CHEMBL4378940	Inhibition of recombinant human MSK2 (2 to end residues) at 10 uM using GRPRTSSFAEGKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	12.0	CHEMBL3125	Homo sapiens	INH	%	12.0
	19147946	CHEMBL4379264	Inhibition of recombinant human MSK2 (2 to end residues) using GRPRTSSFAEGKK as substrate incubated for 40 mins in presence of [gamma-33ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL3125	Homo sapiens	IC50	uM	10.0
	19159642	CHEMBL4382746	Binding affinity to wild-type human partial length N-terminal RPS6KA4 kinase domain 1 expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	99.0	CHEMBL3125	Homo sapiens	Activity	%	99.0
	19159643	CHEMBL4382747	Binding affinity to wild-type human partial length C-terminal RPS6KA4 kinase domain 2 (M375 to T705 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	100.0	CHEMBL3125	Homo sapiens	Activity	%	100.0
	19191364	CHEMBL4389466	Inhibition of wild-type human partial length C-terminal RPS6KA4 kinase domain 2 (M375 to T705 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	44.0	CHEMBL3125	Homo sapiens	INH	%	44.0
	19191365	CHEMBL4389465	Inhibition of wild-type human partial length N-terminal RPS6KA4 kinase domain 1 expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	77.0	CHEMBL3125	Homo sapiens	INH	%	77.0
	19192128	CHEMBL4389942	Inhibition of wild-type human partial length N-terminal RPS6KA4 kinase domain 1 expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	94.0	CHEMBL3125	Homo sapiens	INH	%	94.0
	19192129	CHEMBL4389943	Inhibition of wild-type human partial length C-terminal RPS6KA4 kinase domain 2 (M375 to T705 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	97.0	CHEMBL3125	Homo sapiens	INH	%	97.0
	19200384	CHEMBL4391568	Binding affinity to wild-type human partial length N-terminal RPS6KA4 kinase domain 1 expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	22.0	CHEMBL3125	Homo sapiens	Activity	%	22.0
	19200385	CHEMBL4391569	Binding affinity to wild-type human partial length C-terminal RPS6KA4 kinase domain 2 (M375 to T705 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	69.0	CHEMBL3125	Homo sapiens	Activity	%	69.0
	19242735	CHEMBL4400070	Inhibition of full length recombinant human MSK2 assessed as residual activity at 10 uM using GRPRTSSFAEGKK as substrate incubated for 40 mins in presence of [gamma-33P]ATP at Km concentration by radiometric assay relative to control	B	COc1ccc2c(CCNc3nc(NCc4ccc(=O)[nH]c4)c4nc[nH]c4n3)c[nH]c2c1		CHEMBL4555782	=	Activity	%	96.0	CHEMBL3125	Homo sapiens	Activity	%	96.0
	19276053	CHEMBL4408056	Inhibition of recombinant human MSK2 (2 to end residues) at 1 uM using GRPRTSSFAEGKK as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	78.0	CHEMBL3125	Homo sapiens	INH	%	78.0
	20600664	CHEMBL4603616	Inhibition of recombinant full length human GST-tagged RPS6KA4 expressed in baculovirus expression system using ser/Thr01 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL3125	Homo sapiens	IC50	uM	100.0
	22423431	CHEMBL4674291	Inhibition of human MSK2 using GRPRTSSFAEG as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	102.48	CHEMBL3125	Homo sapiens	Activity	%	102.48
	22423432	CHEMBL4674291	Inhibition of human MSK2 using GRPRTSSFAEG as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	96.14	CHEMBL3125	Homo sapiens	Activity	%	96.14
	22809828	CHEMBL4713352	Inhibition of recombinant human MSK2 (2 to end residues) assessed as residual activity at 1 uM using GRPRTSSFAEGKK as substrate incubated for 40 mins in presence of Km ATP by radiometric scintillation counting analysis relative to control	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	=	Activity	%	70.0	CHEMBL3125	Homo sapiens	Activity	%	70.0
	22843657	CHEMBL4720643	Inhibition of human MSK2 using GRPRTSSFAEG as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.98	CHEMBL3125	Homo sapiens	IC50	10^-9M	2.98
	22844005	CHEMBL4720991	Inhibition of human MSK2 assessed as residual activity using GRPRTSSFAEG as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	97.82	CHEMBL3125	Homo sapiens	Activity	%	97.82
	22844765	CHEMBL4721440	Inhibition of wild-type human partial length N-terminal RPS6KA4 kinase domain 1 expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	108.97	CHEMBL3125	Homo sapiens	Activity	%	108.97
	22952914	CHEMBL4766851	Inhibition of recombinant human MSK2 (2 to end residues) assessed as residual activity at 10 uM using GRPRTSSFAEGKK as substrate incubated for 40 mins in presence of [gamma-33ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	62.0	CHEMBL3125	Homo sapiens	Activity	%	62.0
	23120710	CHEMBL4804435	Inhibition of MSK2 domain 1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855542	=	IC50	nM	-6100.0	CHEMBL3125	Homo sapiens	IC50	uM	-6.1
	23120711	CHEMBL4804435	Inhibition of MSK2 domain 1 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	2900.0	CHEMBL3125	Homo sapiens	IC50	uM	2.9
	23120712	CHEMBL4804435	Inhibition of MSK2 domain 1 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	97500.0	CHEMBL3125	Homo sapiens	IC50	uM	97.5
	23120713	CHEMBL4804435	Inhibition of MSK2 domain 1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855730	=	IC50	nM	-8000.0	CHEMBL3125	Homo sapiens	IC50	uM	-8.0
	23120714	CHEMBL4804435	Inhibition of MSK2 domain 1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4868141	=	IC50	nM	-83600.0	CHEMBL3125	Homo sapiens	IC50	uM	-83.6
	23120715	CHEMBL4804435	Inhibition of MSK2 domain 1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4859660	=	IC50	nM	-36500.0	CHEMBL3125	Homo sapiens	IC50	uM	-36.5
	23121748	CHEMBL4804617	Inhibition of MSK2 domain 1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL3125	Homo sapiens	INH	%	0.0
	23121749	CHEMBL4804617	Inhibition of MSK2 domain 1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL3125	Homo sapiens	INH	%	0.0
	23121750	CHEMBL4804617	Inhibition of MSK2 domain 1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	>	Inhibition	%	90.0	CHEMBL3125	Homo sapiens	INH	%	90.0
	23121751	CHEMBL4804617	Inhibition of MSK2 domain 1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL3125	Homo sapiens	INH	%	0.0
	23121752	CHEMBL4804617	Inhibition of MSK2 domain 1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL3125	Homo sapiens	INH	%	0.0
	23121753	CHEMBL4804617	Inhibition of MSK2 domain 1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	0.0	CHEMBL3125	Homo sapiens	INH	%	0.0
	23122799	CHEMBL4805150	Inhibition of human N-terminal RPS6KA4 kinase domain assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	100.0	CHEMBL3125	Homo sapiens	Activity	%	100.0
	23122800	CHEMBL4805151	Inhibition of human C-terminal RPS6KA4 kinase domain 2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	62.0	CHEMBL3125	Homo sapiens	Activity	%	62.0
	23123494	CHEMBL4805738	Inhibition of human N-terminal RPS6KA4 kinase domain assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	90.0	CHEMBL3125	Homo sapiens	Activity	%	90.0
	23123495	CHEMBL4805739	Inhibition of human C-terminal RPS6KA4 kinase domain 2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	46.0	CHEMBL3125	Homo sapiens	Activity	%	46.0
	23123949	CHEMBL4806193	Inhibition of DNA-tagged human N-terminal RPS6KA4 kinase domain assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	82.0	CHEMBL3125	Homo sapiens	Activity	%	82.0
	23123950	CHEMBL4806194	Inhibition of DNA-tagged human C-terminal RPS6KA4 kinase domain 2 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	89.0	CHEMBL3125	Homo sapiens	Activity	%	89.0
	23125078	CHEMBL4806755	Inhibition of human N-terminal RPS6KA4 kinase domain assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	96.0	CHEMBL3125	Homo sapiens	Activity	%	96.0
	23125079	CHEMBL4806755	Inhibition of human N-terminal RPS6KA4 kinase domain assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL3125	Homo sapiens	Activity	%	100.0
	23125080	CHEMBL4806756	Inhibition of human C-terminal RPS6KA4 kinase domain 2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL3125	Homo sapiens	Activity	%	100.0
	23125081	CHEMBL4806756	Inhibition of human C-terminal RPS6KA4 kinase domain 2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	74.0	CHEMBL3125	Homo sapiens	Activity	%	74.0
	23128551	CHEMBL4807992	Inhibition of RPS6KA4 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL3125	Homo sapiens	Activity	%	75.0
	23128552	CHEMBL4807992	Inhibition of RPS6KA4 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL3125	Homo sapiens	Activity	%	75.0
	23128553	CHEMBL4807992	Inhibition of RPS6KA4 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL3125	Homo sapiens	Activity	%	75.0
	23239309	CHEMBL4828834	Inhibition of ADP(ATP)-biotin probe binding to MSK2 domain 1 in human Kelly cells at 1 uM incubated for 6 hrs by KiNativ profiling analysis	B	CN(C)C/C=C/C(=O)Nc1ccc(O[C@@H]2CCC[C@@H](Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)C2)cc1		CHEMBL4754873	=	Inhibition	%	40.3	CHEMBL3125	Homo sapiens	INH	%	40.3
	23251951	CHEMBL4831279	Inhibition of MSK2 (unknown origin) at 1 uM relative to control	B	NC(=O)c1cccc2c(N[C@H](CN3CCC3)c3ccc(Cl)c(C(F)(F)F)c3)ncnc12		CHEMBL4871106	>	Inhibition	%	80.0	CHEMBL3125	Homo sapiens	INH	%	80.0
	23279634	CHEMBL4836796	Inhibition of MSK2 (unknown origin) assessed as residual activity at 500 nM	B	FC(F)(F)c1n[nH]cc1-c1nc2ccc3[nH]ncc3c2c2c1CCCC2		CHEMBL4593398	<	Activity	%	25.0	CHEMBL3125	Homo sapiens	Activity	%	25.0
Not Active	23317635	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	96.0	CHEMBL3125	Homo sapiens	% Control	%	96.0
Not Active	23317636	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	81.0	CHEMBL3125	Homo sapiens	% Control	%	81.0
Not Active	23318103	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23318104	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	91.0	CHEMBL3125	Homo sapiens	% Control	%	91.0
Not Active	23318769	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	89.0	CHEMBL3125	Homo sapiens	% Control	%	89.0
Not Active	23318770	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	76.0	CHEMBL3125	Homo sapiens	% Control	%	76.0
Not Active	23319253	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	93.0	CHEMBL3125	Homo sapiens	% Control	%	93.0
Not Active	23319254	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	93.0	CHEMBL3125	Homo sapiens	% Control	%	93.0
Not Active	23319890	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23319891	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	75.0	CHEMBL3125	Homo sapiens	% Control	%	75.0
Not Active	23320365	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23320366	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	97.2	CHEMBL3125	Homo sapiens	% Control	%	97.2
Not Active	23321043	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23321044	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23321511	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	94.0	CHEMBL3125	Homo sapiens	% Control	%	94.0
Not Active	23321512	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	73.0	CHEMBL3125	Homo sapiens	% Control	%	73.0
Not Active	23322141	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	84.0	CHEMBL3125	Homo sapiens	% Control	%	84.0
Not Active	23322142	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	68.0	CHEMBL3125	Homo sapiens	% Control	%	68.0
Not Active	23322609	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	97.0	CHEMBL3125	Homo sapiens	% Control	%	97.0
Not Active	23322610	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	90.0	CHEMBL3125	Homo sapiens	% Control	%	90.0
Not Active	23323298	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	94.0	CHEMBL3125	Homo sapiens	% Control	%	94.0
Not Active	23323299	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	81.0	CHEMBL3125	Homo sapiens	% Control	%	81.0
Not Active	23323766	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23323767	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23324068	CHEMBL4880687	MSK2 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	-1.0	CHEMBL3125	Homo sapiens	% inhibition	%	-1.0
Not Active	23324620	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	81.4	CHEMBL3125	Homo sapiens	% Control	%	81.4
Not Active	23324621	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23325255	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23325256	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	97.0	CHEMBL3125	Homo sapiens	% Control	%	97.0
Not Active	23325723	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23325724	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	85.0	CHEMBL3125	Homo sapiens	% Control	%	85.0
Not Active	23326370	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23326371	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	90.0	CHEMBL3125	Homo sapiens	% Control	%	90.0
Not Active	23326838	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	70.0	CHEMBL3125	Homo sapiens	% Control	%	70.0
Not Active	23326839	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	89.0	CHEMBL3125	Homo sapiens	% Control	%	89.0
Not Active	23327538	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23327539	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	91.0	CHEMBL3125	Homo sapiens	% Control	%	91.0
Not Active	23328006	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	96.0	CHEMBL3125	Homo sapiens	% Control	%	96.0
Not Active	23328007	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	84.0	CHEMBL3125	Homo sapiens	% Control	%	84.0
Not Active	23328593	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23328594	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	85.0	CHEMBL3125	Homo sapiens	% Control	%	85.0
Not Active	23329061	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	92.0	CHEMBL3125	Homo sapiens	% Control	%	92.0
Not Active	23329062	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23329432	CHEMBL4881139	MSK2(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	107.0	CHEMBL3125	Homo sapiens	% residual kinase activity	%	107.0
Not Active	23330007	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23330008	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23330475	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23330476	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	93.0	CHEMBL3125	Homo sapiens	% Control	%	93.0
Not Active	23331231	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23331232	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	82.0	CHEMBL3125	Homo sapiens	% Control	%	82.0
Not Active	23331699	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23331700	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23332286	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23332287	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	79.3	CHEMBL3125	Homo sapiens	% Control	%	79.3
Not Active	23332752	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23332753	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Slightly Active	23333470	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	33.5	CHEMBL3125	Homo sapiens	% Control	%	33.5
Not Active	23333471	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	78.8	CHEMBL3125	Homo sapiens	% Control	%	78.8
Not Active	23334109	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23334110	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	79.0	CHEMBL3125	Homo sapiens	% Control	%	79.0
Not Active	23334577	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23334578	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23335556	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23335557	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	83.0	CHEMBL3125	Homo sapiens	% Control	%	83.0
Not Active	23336024	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	87.0	CHEMBL3125	Homo sapiens	% Control	%	87.0
Not Active	23336025	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23336651	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23336652	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	86.0	CHEMBL3125	Homo sapiens	% Control	%	86.0
Not Active	23337119	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23337120	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	90.0	CHEMBL3125	Homo sapiens	% Control	%	90.0
Not Active	23337765	CHEMBL4882136	RPS6KA4 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	103.0	CHEMBL3125	Homo sapiens	% Ctrl	%	103.0
Not Active	23338200	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23338201	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	72.0	CHEMBL3125	Homo sapiens	% Control	%	72.0
Not Active	23338668	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	91.0	CHEMBL3125	Homo sapiens	% Control	%	91.0
Not Active	23338669	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	86.0	CHEMBL3125	Homo sapiens	% Control	%	86.0
Not Active	23339280	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	98.0	CHEMBL3125	Homo sapiens	% Control	%	98.0
Not Active	23339281	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	94.0	CHEMBL3125	Homo sapiens	% Control	%	94.0
Not Active	23339748	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	78.0	CHEMBL3125	Homo sapiens	% Control	%	78.0
Not Active	23339749	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	71.0	CHEMBL3125	Homo sapiens	% Control	%	71.0
Not Active	23340385	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	85.0	CHEMBL3125	Homo sapiens	% Control	%	85.0
Not Active	23340386	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	81.0	CHEMBL3125	Homo sapiens	% Control	%	81.0
Not Active	23340853	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	85.0	CHEMBL3125	Homo sapiens	% Control	%	85.0
Not Active	23340854	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23341510	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23341511	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23341978	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23341979	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	81.0	CHEMBL3125	Homo sapiens	% Control	%	81.0
Not Active	23342594	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23342595	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	79.0	CHEMBL3125	Homo sapiens	% Control	%	79.0
Not Active	23343062	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23343063	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23343692	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	88.0	CHEMBL3125	Homo sapiens	% Control	%	88.0
Not Active	23343693	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	86.0	CHEMBL3125	Homo sapiens	% Control	%	86.0
Not Active	23344160	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	73.0	CHEMBL3125	Homo sapiens	% Control	%	73.0
Not Active	23344161	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	81.0	CHEMBL3125	Homo sapiens	% Control	%	81.0
Not Active	23344798	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23344799	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	80.0	CHEMBL3125	Homo sapiens	% Control	%	80.0
Not Active	23345371	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	96.0	CHEMBL3125	Homo sapiens	% Control	%	96.0
Not Active	23345372	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	72.0	CHEMBL3125	Homo sapiens	% Control	%	72.0
Not Active	23345839	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23345840	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	85.0	CHEMBL3125	Homo sapiens	% Control	%	85.0
Not Active	23346416	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23346417	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23346884	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	81.3	CHEMBL3125	Homo sapiens	% Control	%	81.3
Not Active	23346885	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	95.1	CHEMBL3125	Homo sapiens	% Control	%	95.1
Not Active	23347484	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	94.5	CHEMBL3125	Homo sapiens	% Control	%	94.5
Not Active	23347485	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	72.5	CHEMBL3125	Homo sapiens	% Control	%	72.5
Not Active	23347976	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23347977	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23348555	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23348556	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23349023	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	87.0	CHEMBL3125	Homo sapiens	% Control	%	87.0
Not Active	23349024	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	93.0	CHEMBL3125	Homo sapiens	% Control	%	93.0
Not Active	23349610	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23349611	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23350228	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23350229	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23350696	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	78.0	CHEMBL3125	Homo sapiens	% Control	%	78.0
Not Active	23350697	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	97.0	CHEMBL3125	Homo sapiens	% Control	%	97.0
Not Active	23351301	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23351302	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	96.0	CHEMBL3125	Homo sapiens	% Control	%	96.0
Not Active	23351769	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23351770	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	97.0	CHEMBL3125	Homo sapiens	% Control	%	97.0
Not Active	23352217	CHEMBL4882906	RPS6KA4 (MSK2) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	7.684	CHEMBL3125	Homo sapiens	% Inhibition	%	7.6837
Not Active	23352793	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23352794	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	75.0	CHEMBL3125	Homo sapiens	% Control	%	75.0
Not Active	23353261	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23353262	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	81.0	CHEMBL3125	Homo sapiens	% Control	%	81.0
Not Active	23354143	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23354144	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23354611	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	88.0	CHEMBL3125	Homo sapiens	% Control	%	88.0
Not Active	23354612	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23355343	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	86.0	CHEMBL3125	Homo sapiens	% Control	%	86.0
Not Active	23355344	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23355811	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	74.0	CHEMBL3125	Homo sapiens	% Control	%	74.0
Not Active	23355812	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23356447	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	91.0	CHEMBL3125	Homo sapiens	% Control	%	91.0
Not Active	23356448	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23356915	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	99.0	CHEMBL3125	Homo sapiens	% Control	%	99.0
Not Active	23356916	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23357524	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	85.0	CHEMBL3125	Homo sapiens	% Control	%	85.0
Not Active	23357525	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23358171	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	98.0	CHEMBL3125	Homo sapiens	% Control	%	98.0
Not Active	23358172	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23358639	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23358640	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	92.0	CHEMBL3125	Homo sapiens	% Control	%	92.0
Not Active	23359225	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23359226	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	82.3	CHEMBL3125	Homo sapiens	% Control	%	82.3
Not Active	23359823	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23359824	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	69.0	CHEMBL3125	Homo sapiens	% Control	%	69.0
Not Active	23360291	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23360292	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	80.0	CHEMBL3125	Homo sapiens	% Control	%	80.0
Not Active	23360876	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	82.0	CHEMBL3125	Homo sapiens	% Control	%	82.0
Not Active	23360877	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	85.0	CHEMBL3125	Homo sapiens	% Control	%	85.0
Not Active	23361344	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23361345	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	96.0	CHEMBL3125	Homo sapiens	% Control	%	96.0
Not Active	23361917	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	84.0	CHEMBL3125	Homo sapiens	% Control	%	84.0
Not Active	23361918	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	68.0	CHEMBL3125	Homo sapiens	% Control	%	68.0
Not Active	23362453	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	95.0	CHEMBL3125	Homo sapiens	% Control	%	95.0
Not Active	23362454	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23362921	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	82.0	CHEMBL3125	Homo sapiens	% Control	%	82.0
Not Active	23362922	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23364563	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	95.0	CHEMBL3125	Homo sapiens	% Control	%	95.0
Not Active	23364564	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	90.0	CHEMBL3125	Homo sapiens	% Control	%	90.0
Not Active	23365031	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23365032	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	89.0	CHEMBL3125	Homo sapiens	% Control	%	89.0
Not Active	23365770	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23365771	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	96.0	CHEMBL3125	Homo sapiens	% Control	%	96.0
Not Active	23366313	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	95.0	CHEMBL3125	Homo sapiens	% Control	%	95.0
Not Active	23366314	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	95.0	CHEMBL3125	Homo sapiens	% Control	%	95.0
Not Active	23366903	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	85.0	CHEMBL3125	Homo sapiens	% Control	%	85.0
Not Active	23366904	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	98.0	CHEMBL3125	Homo sapiens	% Control	%	98.0
Not Active	23367371	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	83.0	CHEMBL3125	Homo sapiens	% Control	%	83.0
Not Active	23367372	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	90.0	CHEMBL3125	Homo sapiens	% Control	%	90.0
Not Active	23367736	CHEMBL4884089	RPS6KA4 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	107.0	CHEMBL3125	Homo sapiens	% Residual activity with Skepinone-L	%	107.0
Not Active	23368249	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	91.0	CHEMBL3125	Homo sapiens	% Control	%	91.0
Not Active	23368250	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	89.0	CHEMBL3125	Homo sapiens	% Control	%	89.0
Not Active	23368717	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	94.0	CHEMBL3125	Homo sapiens	% Control	%	94.0
Not Active	23368718	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	73.0	CHEMBL3125	Homo sapiens	% Control	%	73.0
Not Active	23369316	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23369317	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	94.0	CHEMBL3125	Homo sapiens	% Control	%	94.0
Not Active	23369784	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	80.0	CHEMBL3125	Homo sapiens	% Control	%	80.0
Not Active	23369785	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	73.0	CHEMBL3125	Homo sapiens	% Control	%	73.0
Not Active	23370151	CHEMBL4884394	MSK2(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	27.0	CHEMBL3125	Homo sapiens	% residual kinase activity	%	27.0
Active	23370752	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	8.9	CHEMBL3125	Homo sapiens	% Control	%	8.9
Not Active	23370753	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23371220	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23371221	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	89.0	CHEMBL3125	Homo sapiens	% Control	%	89.0
Not Active	23372029	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	97.0	CHEMBL3125	Homo sapiens	% Control	%	97.0
Not Active	23372030	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23372497	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	86.0	CHEMBL3125	Homo sapiens	% Control	%	86.0
Not Active	23372498	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	91.0	CHEMBL3125	Homo sapiens	% Control	%	91.0
	23372884	CHEMBL4884849	MSK2(R6A4LGRJ) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL3125	Homo sapiens	pIC50		6.0
	23373293	CHEMBL4885140	MSK2(R6A4LGRJ) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL3125	Homo sapiens	pIC50		6.0
	23373649	CHEMBL4885426	MSK2(R6A4LGRJ) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL3125	Homo sapiens	pIC50		6.0
Not Active	23375372	CHEMBL4886354	ribosomal protein S6 kinase, 90kDa, polypeptide 4 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	2.0	CHEMBL3125	Homo sapiens	% inhibition	%	2.0
Not Active	23375924	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	65.0	CHEMBL3125	Homo sapiens	% Control	%	65.0
Not Active	23375925	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	72.0	CHEMBL3125	Homo sapiens	% Control	%	72.0
Not Active	23376392	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	70.0	CHEMBL3125	Homo sapiens	% Control	%	70.0
Not Active	23376393	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	95.0	CHEMBL3125	Homo sapiens	% Control	%	95.0
Not Active	23376969	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23376970	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	80.0	CHEMBL3125	Homo sapiens	% Control	%	80.0
Not Active	23377437	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23377438	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	74.0	CHEMBL3125	Homo sapiens	% Control	%	74.0
Not Active	23378297	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23378298	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	72.0	CHEMBL3125	Homo sapiens	% Control	%	72.0
Not Active	23378765	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23378766	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	88.0	CHEMBL3125	Homo sapiens	% Control	%	88.0
Not Active	23379932	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	94.0	CHEMBL3125	Homo sapiens	% Control	%	94.0
Not Active	23379933	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	65.0	CHEMBL3125	Homo sapiens	% Control	%	65.0
Not Active	23380400	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	79.0	CHEMBL3125	Homo sapiens	% Control	%	79.0
Not Active	23380401	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23381094	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23381095	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	85.0	CHEMBL3125	Homo sapiens	% Control	%	85.0
Not Active	23381742	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	63.0	CHEMBL3125	Homo sapiens	% Control	%	63.0
Not Active	23381743	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	92.0	CHEMBL3125	Homo sapiens	% Control	%	92.0
Not Active	23382210	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	95.0	CHEMBL3125	Homo sapiens	% Control	%	95.0
Not Active	23382211	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23382834	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	85.0	CHEMBL3125	Homo sapiens	% Control	%	85.0
Not Active	23382835	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	57.0	CHEMBL3125	Homo sapiens	% Control	%	57.0
Not Active	23383302	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	81.0	CHEMBL3125	Homo sapiens	% Control	%	81.0
Not Active	23383303	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	72.0	CHEMBL3125	Homo sapiens	% Control	%	72.0
Not Active	23383979	CHEMBL4887582	RPS6KA4 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	96.0	CHEMBL3125	Homo sapiens	% Ctrl	%	96.0
Not Active	23384362	CHEMBL4887957	MSK2(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	-3.96	CHEMBL3125	Homo sapiens	% inhibition	%	-3.96
Not Active	23384711	CHEMBL4888237	RPS6KA4 (MSK2) SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	8.0	CHEMBL3125	Homo sapiens	% Inhibition	%	8.0
Not Active	23385217	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	86.0	CHEMBL3125	Homo sapiens	% Control	%	86.0
Not Active	23385218	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
Not Active	23385684	CHEMBL4879941	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.1-N-terminal)	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	94.0	CHEMBL3125	Homo sapiens	% Control	%	94.0
Not Active	23385685	CHEMBL4879942	KinomeScan assay: inhibition of RPS6KA4(Kin.Dom.2-C-terminal)	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL3125	Homo sapiens	% Control	%	100.0
